Scolaris Content Display Scolaris Content Display

Ecografía Doppler umbilical y fetal en embarazos de alto riesgo

Collapse all Expand all

References

Referencias de los estudios incluidos en esta revisión

Almstrom 1992 {published data only}

Almstrom H, Axelsson O, Cnattingius S, Ekman G, Maesel A, Ulmsten U, et al. Comparison of umbilical‐artery velocimetry and cardiotocography for surveillance of small‐for‐gestational‐age fetuses. Lancet 1992;340:936‐40. CENTRAL
Almstrom H, Axelsson O, Ekman G, Ingemarsson I, Maesel A, Arstrom K, et al. Umbilical artery velocimetry may influence clinical interpretation of intrapartum cardiotocograms. Acta Obstetricia et Gynecologica Scandinavica 1995;74:526‐9. CENTRAL
Marsal K, Almstrom H, Axelsson O, Cnattingius S, Ekman G, Maesel A, et al. Umbilical artery velocimetry is more effective than cardiotocography for surveillance of growth retarded fetuses. Journal of Perinatal Medicine 1991;19(Suppl 2):84. CENTRAL

Biljan 1992 {published and unpublished data}

Biljan M, Haddad N, McVey K, Williams J. Efficiency of continuous‐wave Doppler in screening high risk pregnancies in a district general hospital (a prospective randomized study on 674 singleton pregnancies). Proceedings of 26th British Congress of Obstetrics and Gynaecology; 1992 July 7‐10; Manchester, UK. 1992:6. CENTRAL
Biljan MM, McVey KP, Haddad NG. The value of continuous wave doppler assessment of fetal umbilical artery in management of "at risk" pregnancies. Proceedings of 2nd European Congress on Prostaglandins in Reproduction; 1991 April 30 ‐ May 3; The Hague, Netherlands. 1991:189. CENTRAL

Burke 1992 {published data only}

Burke G, Stuart B, Crowley P, Ni Scanaill S, Drumm J. Does Doppler ultrasound alter the management of high‐risk pregnancy? Care concern and cure in perinatal medicine. 13th European Congress of Perinatal Medicine; 1992 May; Amsterdam, The Netherlands. Parthenon, 1992:597‐604. CENTRAL
Burke G, Stuart B, Crowley P, Ni Scanaill S, Drumm J. Does Doppler ultrasound alter the management of high‐risk pregnancy?. Journal of Perinatal Medicine 1992;20(Suppl 1):266. CENTRAL

De Rochambeau 1992 {published data only}

De Rochambeau B, Jabbour N, Mellier G. Umbilical doppler velocimetry in prolonged pregnancies [La velocimetrie Doppler ombilicale dans les grossesses prolongees]. Revue Francaise de Gynecologie et d Obstetrique 1992;87(5):289‐94. CENTRAL

Giles 2003 {published data only}

Giles W, Bisits A, O'Callaghan S. The doppler assessment in multiple pregnancy study (damp) and metaanalyses of doppler and twins. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S17. CENTRAL
Giles W, Bisits A, O'Callaghan S, Gill A. The doppler assessment in multiple pregnancy randomised controlled trial of ultrasound biometry versus umbilical artery doppler ultrasound and biometry in twin pregnancy. BJOG: an international journal of obstetrics and gynaecology 2003;110(6):593‐7. CENTRAL

Haley 1997 {published data only}

Haley J, Tuffnell DJ, Johnson N. Randomised controlled trial of cardiotocography versus umbilical artery Doppler in the management of small for gestational age fetuses. British Journal of Obstetrics and Gynaecology 1997;104(4):431‐5. CENTRAL

Hofmeyr 1991 {published data only}

Hofmeyr GJ, Pattinson R, Buckley D, Jennings J, Redman CWG. Umbilical artery resistance index as a screening test for fetal well‐being. II. Randomized feasibility study. Obstetrics & Gynecology 1991;78:359‐62. CENTRAL

Johnstone 1993 {published data only}

Johnstone FD, Prescott R, Hoskins P, Greer IA, McGlew T, Compton M. The effect of introduction of umbilical Doppler recordings to obstetric practice. British Journal of Obstetrics and Gynaecology 1993;100:733‐41. CENTRAL

Lees 2013 {published data only}

Cambridge Consortium ongoing. Trial of umbilical and fetal flow in Europe (TRUFFLE). National Research Register (www.nrr.nhs.uk) (accessed 6 July 2006). CENTRAL
Lees C, Baumgartner H. The TRUFFLE study ‐ a collaborative publicly funded project from concept to reality: how to negotiate an ethical, administrative and funding obstacle course in the European Union. Ultrasound in Obstetrics and Gynecology 2005;25:105‐7. CENTRAL
Lees C, Marlow N, Arabin B, Bilardo CM, Brezinka C, Derks JB, et al. Perinatal morbidity and mortality in early‐onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (truffle). Ultrasound in Obstetrics & Gynecology 2013;42(4):400‐8. CENTRAL
Lees CC, Marlow N, Van Wassenaer‐Leemhuis A, Arabin B, Bilardo CM, Brezinka C, et al. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet 2015;385(9983):2162‐72. CENTRAL
Van Wassenaer‐Leemhuis AG, Marlow N, Lees C, Wolf H. Can severe neonatal morbidity predict neurodevelopmental impairment (NDI) at two years in growth restricted infants? Secondary analyses from TRUFFLE (Trial of Randomized Umbilical and Fetal Flow in Europe). Pediatric Academic Socieities Annual Meeting; 2015 April 25‐28; San Diego, California, USA. 2015. CENTRAL

Neales 1994 [pers comm] {published data only}

Neales K. (St Mary's Hospital, Manchester, UK). [personal communication]. Letter to: Z Alfirevic (Department of Women's and Children's Health, The University of Liverpool, Liverpool, UK) 24 January 1994; Vol. Located at: Cochrane Office, Department of Women's and Children's Health, The University of Liverpool, Liverpool, UK. CENTRAL

Newnham 1991 {published data only}

Newnham JP, O'Dea MRA, Reid KP, Diepeveen DA. Doppler flow velocity waveform analysis in high risk pregnancies: a randomized controlled trial. British Journal of Obstetrics and Gynaecology 1991;98:956‐63. CENTRAL

Nienhuis 1997 {published data only}

Nienhuis SJ. Costs and effects of Doppler ultrasound measurements in suspected intrauterine growth retardation. A randomised clinical trial [thesis]. Maastricht: Universitaire Pers Maastricht, 1995. CENTRAL
Nienhuis SJ, Ruissen CJ, Hoogland HJ, Gerver JW, Vles J, De Haan J. Cost‐effectiveness of a doppler policy in suspected intrauterine growth retardation ‐ a randomized controlled trial. Proceedings of 13th World Congress of Gynaecology and Obstetrics (FIGO); 1991 Sept 15‐20; Singapore. 1991:32. CENTRAL
Nienhuis SJ, Vles JS, Gerver WJ, Hoogland HJ. Doppler ultrasonography in suspected intrauterine growth retardation: a randomized clinical trial. Ultrasound in Obstetrics & Gynecology 1997;9(1):6‐13. CENTRAL
Ruissen CJ, Nienhuis SJ, Hoogland HJ, Vles JFH, Gerver WJ, De Haan J. Cost‐effectiveness of a Doppler based policy of suspected intrauterine growth retardation ‐ a randomised controlled trial. Journal of Maternal Fetal Investigation 1992;1:126. CENTRAL

Nimrod 1992 {published data only}

Nimrod C, Yee J, Hopkins C, Pierce P, Lange I, Fick G, et al. The utility of pulsed Doppler studies in the evaluation of postdate pregnancies. Journal of Maternal Fetal Investigation 1992;1:127. CENTRAL

Norman 1992 {published data only}

Norman K, Pattinson RC, Carstens E. Doppler velocimetry in recurrent pregnancy loss: is there a role? Proceedings of 11th Conference on Priorities in Perinatal Care in South Africa; 1992 March; Caledon, South Africa. 1992:71‐4. CENTRAL

Ott 1998 {published data only}

Ott WJ, Mora G, Arias F, Sunderji S, Sheldon G. Comparison of the modified biophysical profile to a new biophysical profile incorporating the middle cerebral artery to umbilical artery velocity flow systolic/diastolic ratio. American Journal of Obstetrics and Gynecology 1998;178(6):1346‐53. CENTRAL

Pattinson 1994 {published data only}

Pattinson R, Norman K, Odendaal HJ. Management of fetuses suspected of IUGR but with EDVs of the umbilical artery: a randomised controlled trial. Proceedings of 26th British Congress of Obstetrics and Gynaecology; 1992 July 7‐10; Manchester, UK. 1992:5. CENTRAL
Pattinson RC, Norman K, Odendaal HJ. The role of doppler velocimetry in the management of pregnancies: a randomized controlled trial. Proceedings of 11th Conference on Priorities in Perinatal Care in South Africa; 1992 March; Caledon, South Africa. 1992:59‐63. CENTRAL
Pattinson RC, Norman K, Odendaal HJ. The role of Doppler velocimetry in the management of high risk pregnancies. British Journal of Obstetrics and Gynaecology 1994;101:114‐20. CENTRAL

Trudinger 1987 {published data only}

Trudinger BJ, Cook CM, Giles WB, Connelly AJ, Thompson RS. Umbilical artery flow velocity waveforms in high‐risk pregnancy: randomised controlled trial. Lancet 1987;1:188‐90. CENTRAL

Tyrrell 1990 {published data only}

Lilford RJ. (St James' University Hospital, Leeds, UK). [personal communication]. Letter to: The Oxford Database of Perinatal Trials (copy) 24 February 1989; Vol. Located at: Cochrane Office, Department of Women's and Children's Health, The University of Liverpool, Liverpool, UK. CENTRAL
Tyrrell SN, Lilford RJ, MacDonald HN, Nelson EJ, Porter J, Gupta JK. Randomized comparison of routine vs highly selective use of Doppler ultrasound and biophysical scoring to investigate high risk pregnancies. British Journal of Obstetrics and Gynaecology 1990;97:909‐16. CENTRAL

Williams 2003 {published data only}

Williams K, Farquharson D, Bebbington M, Dansereau J, Galerneau F, Wilson RD, et al. A randomized controlled clinical trial comparing non stress testing versus doppler velocimetry as a screening test in a high risk population. American Journal of Obstetrics and Gynecology 2000;182(1 Pt 2):S109. CENTRAL
Williams KP, Farquharson DF, Bebbington M, Dansereau J, Galerneau F, Wilson RD, et al. Screening for fetal well‐being in a high‐risk pregnant population comparing the nonstress test with umbilical artery doppler velocimetry: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology 2003;188(5):1366‐71. CENTRAL

Referencias de los estudios excluidos de esta revisión

Davies 1992 {published data only}

Davies JA, Gallivan S, Spencer JAD. Randomised controlled trial of doppler ultrasound screening of placental perfusion during pregnancy. Lancet 1992;340:1299‐303. CENTRAL

Gonsoulin 1991 {published data only}

Gonsoulin W. Umbilical artery Doppler waveform analysis: a randomized study on effect on outcome. American Journal of Obstetrics and Gynecology 1991;164:370. CENTRAL

Mason 1993 {published data only}

Mason GC, Lilford RJ, Porter J, Nelson E, Tyrell S. Randomised comparison of routine vs highly selective use of Doppler ultrasound in low risk pregnancies. British Journal of Obstetrics and Gynaecology 1993;100:130‐3. CENTRAL

McCowan 1996 {published data only}

McCowan LME, Harding J, Roberts AB, Barker S, Townend K. Perinatal morbidity in small for gestational age fetuses in relation to umbilical doppler. Proceedings of the 14th Annual Congress of the Australian Perinatal Society in conjunction with the New Zealand Perinatal Society; 1996 March 24‐27; Adelaide, Australia. 1996:10. CENTRAL

McParland 1988 {published data only}

McParland P, Pearce JM. Doppler blood flow in pregnancy. Placenta 1988;9:427‐50. CENTRAL

Newnham 1993 {published data only}

Newnham JP, Evans SF, Michael CA, Stanley FJ, Landau LI. Effects of frequent ultrasound during pregnancy: a randomised controlled trial. Lancet 1993;342:887‐91. CENTRAL

Omtzigt 1994 {published data only}

Omtzigt AWJ. Clinical value of umbilical doppler velocimetry [thesis]. Utrecht: University of Utrecht, 1990. CENTRAL
Omtzigt AWJ, Bruinse HW, Reuwer PJHM. A randomized controlled trial on the clinical value of umbilical Doppler velocimetry. I. Obstetrical management. Proceedings of 12th European Congress of Perinatal Medicine; 1990 Sept 11‐14; Lyon, France. 1990:210. CENTRAL
Omtzigt AWJ, Bruinse HW, Reuwer PJHM. A randomized controlled trial on the clinical value of umbilical Doppler velocimetry: neonatal outcome. Proceedings of 12th European Congress of Perinatal Medicine; 1990 Sept 11‐14; Lyon, France. 1990:189. CENTRAL
Omtzigt AWJ, Reuwer PJHM, Bruinse HW. A randomized controlled trial on the clinical value of umbilical Doppler velocimetry in antenatal care. American Journal of Obstetrics and Gynecology 1994;170:625‐34. CENTRAL

Pearce 1992 {published data only}

Pearce JM. The application of uteroplacental waveforms to complicated pregnancies. Doppler Ultrasound in Perinatal Medicine. Oxford: Oxford University Press, 1992:159‐77. CENTRAL

Schneider 1992 {published data only}

Schneider KTM, Renz S, Furstenau U, Amberg‐Wendland D, Prochaska D, Graeff H. Doppler flow measurements as a screening method during pregnancy: is it worth the effort?. Journal of Maternal Fetal Investigation 1992;1:125. CENTRAL

Whittle 1994 {published data only}

Whittle MJ, Hanretty KP, Primrose MH, Neilson JP. Screening for the compromised fetus: a randomized trial of umbilical artery velocimetry in unselected pregnancies. American Journal of Obstetrics and Gynecology 1994;170:555‐9. CENTRAL

Al‐Ghazali 1990

Al‐Ghazali WH, Chapman MG, Rissik JM, Allan LD. The significance of absent end‐diastolic flow in the umbilical artery combined with reduced fetal cardiac output estimation in pregnancies at high risk for placental insufficiency. Journal of Obstetrics and Gynaecology 1990;10:271‐5.

Alfirevic 1995

Alfirevic Z, Neilson JP. Doppler ultrasonography in high‐risk pregnancies: systematic review with meta‐analysis. American Journal of Obstetrics and Gynecology 1995;172:1379‐87.

Alfirevic 2002

Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. European Journal Obstetetrics & Gynecology and Reproductive Biology 2002;101(1):6‐14.

Alfirevic 2015

Alfirevic Z, Stampalija T, Medley N. Fetal and umbilical Doppler ultrasound in normal pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 4. [DOI: 10.1002/14651858.CD001450.pub4]

Almstrom 1995

Almstrom H, Axelsson O, Ekman G, Ingemarsson I, Maesel A, Arstrom K, et al. Umbilical artery velocimetry may influence clinical interpretation of intrapartum cardiotocograms. Acta Obstetricia et Gynecologica Scandinavica 1995;74:526‐9.

Baschat 2001

Baschat AA, Gembruch U, Harman CR. The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound in Obstetrics & Gynecology 2001;18:571‐7.

Baschat 2002

Baschat AA, Gembruch U. Evaluation of the fetal coronary circulation. Ultrasound in Obstetrics & Gynecology 2002;20:405‐12.

Bernstein 2000

Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very‐low‐birth‐weight neonates with intrauterine growth restriction. The Vermont Oxford Network. American Journal of Obstetrics and Gynecology 2000;182:198‐206.

Bilardo 1990

Bilardo CM, Nicolaides KH, Campbell S. Doppler measurements of fetal and uteroplacental circulations: relationship with umbilical venous blood gases measured at cordocentesis. American Journal of Obstetrics and Gynecology 1990;162:115‐20.

Bilardo 2004

Bilardo CM, Wolf H, Stigter RH, Ville Y, Baez E, Visser GHA, et al. Relationship between monitoring parameters and outcome in severe, early intrauterine growth restriction. Ultrasound in Obstetrics & Gynecology 2004;23:119‐25.

BJOG 1995

Anonymous. Retraction of articles. British Journal of Obstetrics and Gynaecology 1995;102(11):853.

Bricker 2007

Bricker L, Neilson JP. Routine Doppler ultrasound in pregnancy. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD001450.pub2]

Burns 1993

Burns PN. Principles of Doppler and color flow. Radiology in Medicine 1993;85:3‐16.

Cheema 2004

Cheema R, Dubiel M, Breborowicz G, Gudmundsson S. Fetal cerebral venous Doppler velocimetry in normal and high‐risk pregnancy. Ultrasound in Obstetrics & Gynecology 2004;24:147‐53.

Chen 1996

Chen JF, Fowlkes JB, Carson PL, Rubin JM, Adler RS. Autocorrelation of integrated power Doppler signals and its application. Ultrasound in Medicine and Biology 1996;22:1053‐7.

CONSORT 2001

Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel‐group randomised trials. Lancet 2001;357(9263):1191‐4.

Devane 2007

Devane D, Begley CM, Clarke M, Horey D, Oboyle C. Evaluating maternity care: a core set of outcome measures. Birth 2007;34(2):164‐72.

Ferrazzi 2002

Ferrazzi E, Bozzo M, Rigano S, Bellotti M, Morabito A, Pardi G, et al. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth‐restricted fetus. Ultrasound in Obstetrics & Gynecology 2002;19:140‐6.

Figueras 2008

Figueras F, Eixarch E, Gratacos E, Gardosi J. Predictiveness of antenatal umbilical artery Doppler for adverse pregnancy outcome in small‐for‐gestational‐age babies according to customised birthweight centiles: population‐based study. BJOG: an international journal of obstetrics and gynaecology 2008;115:590‐4.

Fisk 2001

Fisk NM, Smith RP. Fetal growth restriction; small for gestational age. In: Chamberlain G, Steer P editor(s). Turnbull's Obstetrics. 3rd Edition. Edinburgh: Churchill Livingstone, 2001:197‐209.

Fitzgerald 1977

Fitzgerald DE, Drumm JE. Non‐invasive measurement of the human circulation using ultrasound: a new method. British Medical Journal 1977;2:1450‐1.

Gates 2004

Gates S, Brocklehurst P. How should randomised trial including multiple pregnancies be analysed?. BJOG: an international journal of obstetrics and gynaecology 2004;111:213‐9.

Giles 1985

Giles WB, Trudinger BJ, Baird PJ. Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation. British Journal of Obstetrics and Gynaecology 1985;92:31‐8.

Graves 2007

Graves CR. Antepartum fetal surveillance and timing of delivery in the pregnancy complicated by diabetes mellitus. Clinical Obstetrics and Gynecology 2007;50(4):1007‐13.

Greer 1999

Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 1999;353(9160):1258‐65.

GRIT 2003

GRIT Study Group. A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG: an international journal of obstetrics and gynaecology 2002;110:27‐32.

GRIT 2004

GRIT study group. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004;364:513‐20.

Grivell 2015

Grivell RM, Alfirevic Z, Gyte Gillian ML, Devane D. Antenatal cardiotocography for fetal assessment. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD007863.pub4]

Harbord 2006

Harbord RM, Egger M, Sterne JA. A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25:3443‐57.

Hecher 2001

Hecher K, Bilardo CM, Stigter RH, Ville Y, Hackeloer BJ, Kok HJ, et al. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound in Obstetrics & Gynecology 2001;18:564‐70.

Higgins 2011

Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Imdad 2011

Imdad A, Yakoob MY, Siddiqui S, Bhutta ZA. Screening and triage of intrauterine growth restriction (IUGR) in general population and high risk pregnancies: a systematic review with a focus on reduct ion of IUGR related stillbirths . BMC Public Health 2011 ; 11 ( Suppl 3 ):S1.

Lalor 2008

Lalor JG, Fawole B, Alfirevic Z, Devane D. Biophysical profile for fetal assessment in high risk pregnancies. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD000038.pub2]

Lees 2005

Lees C, Baumgartner H. The TRUFFLE study ‐ a collaborative publicly funded project from concept to reality: how to negotiate an ethical, administrative and funding obstacle course in the European Union. Ultrasound in Obstetrics and Gynecology 2005;25:105‐7. CENTRAL

Lees 2015

Lees CC, Marlow N, Van Wassenaer‐Leemhuis A, Arabin B, Bilardo CM, Brezinka C, et al. 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial. Lancet 2015;385(9983):2162‐72. CENTRAL

Mari 2009

Mari G. Doppler ultrasonography in obstetrics: from the diagnosis of fetal anemia to the treatment of intrauterine growth‐restricted fetuses. American Journal of Obstetrics and Gynecology 2009;200(6):613.e1‐613.e9.

Mires 2000

Mires GJ, Patel NB, Dempster J. Review: The value of fetal umbilical artery flow velocity waveforms in the prediction of adverse fetal outcome in high risk pregnancies. Journal of Obstetrics and Gynaecology 2000;10:261‐70.

Neilson 1987

Neilson JP. Doppler ultrasound. British Journal of Obstetrics and Gynaecology 1987;94:929‐34.

Nicholaides 1988

Nicholaides KH, Bilardo CM, Soothill PW, Campbell S. Absence of end diastolic frequencies in umbilical artery: a sign of fetal hypoxia and acidosis. BMJ 1988;297(6655):1026‐7.

Nienhuis 1995

Nienhuis SJ. Costs and effects of Doppler ultrasound measurements in suspected intrauterine growth retardation. A randomised clinical trial [thesis]. Maastricht: Universitaire Pers Maastricht, 1995.

Ortibus 2009

Ortibus E, Lopriore E, Deprest J, Vandenbussche FP, Walther FJ, Diemert A, et al. The pregnancy and long‐term neurodevelopmental outcome of monochorionic diamniotic twin gestations: a multicenter prospective cohort study from the first trimester onward. American Journal of Obstetrics and Gynecology 2009;200(5):494.e1‐494.e8.

Owen 2001

Owen P. Fetal assessment in the third trimester: fetal growth and biophysical methods. In: Chamberlain G, Steer P editor(s). Turnbull's Obstetrics. 3rd Edition. Edinburgh: Churchill Livingstone, 2001.

RevMan 2014 [Computer program]

Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Stampalija 2010

Stampalija T, Gyte GML, Alfirevic Z. Utero‐placental Doppler ultrasound for improving pregnancy outcome. Cochrane Database of Systematic Reviews 2010, Issue 9. [DOI: 10.1002/14651858.CD008363.pub2]

Thompson 1990

Thompson RS, Trudinger BJ. Doppler waveform pulsatility index and resistance, pressure and flow in the umbilical placental circulation: an investigation using a mathematical model. Ultrasound in Medicine and Biology 1990;16:449.

Trudinger 1985a

Trudinger BJ, Giles WB, Cook CM, Bombardieri J, Collins L. Fetal umbilical artery flow velocity waveforms and placental resistance: clinical significance. British Journal of Obstetrics and Gynaecology 1985;92:23‐30.

Trudinger 1985b

Trudinger BJ, Giles WB, Cook CM. Uteroplacental blood flow velocity‐time waveform in normal and complicated pregnancy. British Journal of Obstetrics and Gynaecology 1985;92:39‐45.

Weiner 1990

Weiner CP. The relationship between the umbilical artery systolic/diastolic ratio and umbilical blood gas measurements in specimens obtained by cordocentesis. American Journal of Obstetrics and Gynecology 1990;162:1198‐202.

Westergaard 2001

Westergaard HB, Langhoff‐Roos J, Lingman G, Marsal K, Kreiner S. A critical appraisal of the use of umbilical artery Doppler ultrasound in high‐risk pregnancies: use of meta‐analyses in evidence‐based obstetrics. Ultrasound in Obstetrics & Gynecology 2001;17:466‐76.

Referencias de otras versiones publicadas de esta revisión

Alfirevic 2010

Alfirevic Z, Stampalija T, Gyte GML. Fetal and umbilical Doppler ultrasound in high‐risk pregnancies. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD007529.pub2]

Alfirevic 2013

Alfirevic Z, Stampalija T, Gyte GML. Fetal and umbilical Doppler ultrasound in high‐risk pregnancies. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD007529.pub3]

Neilson 1995

Neilson JP, Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database of Systematic Reviews 1995, Issue 1. [DOI: 10.1002/14651858.CD000073]

Neilson 1996

Neilson JP, Alfirevic Z. Doppler ultrasound for fetal assessment in high risk pregnancies. Cochrane Database of Systematic Reviews 1996, Issue 4. [DOI: 10.1002/14651858.CD000073.pub2]

Characteristics of studies

Characteristics of included studies [ordered by study ID]

Jump to:

Almstrom 1992

Methods

2‐arm prospective RCT; randomised block design; individual women.

Participants

Singleton pregnancies with suspected IUGR at 31 completed weeks of pregnancy. IUGR if fetal weight < 2 SD below the mean at 31 weeks.

N = 427 women.

Interventions

Intervention: Doppler of umbilical artery only every 2 weeks till birth unless:

  • fetal weight 28% to 33% below mean, then every week;

  • fetal weight > 34% below the mean, then twice a week and admission to hospital.

Comparison: CTG (NST).

Outcomes

Primary: GA at delivery, frequency of CS, frequency of operative delivery for fetal distress, CS, vacuum, forceps, length of stay at NICU.

Secondary: number of fetal monitoring occasions, duration of antenatal hospital stay, frequency of labour induction, birthweight, frequency of small‐for‐dates infants, Apgar score at 1 min and 5 min, need for respiratory support.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Randomised block design.

No information about how the randomisation was performed.

Allocation concealment (selection bias)

Unclear risk

Sealed numbered envelopes according to a randomisation block design.

This may mean separate randomisation schedules for the 4 different hospitals. No mention of whether the envelopes were opaque.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No women were lost to follow‐up.

3 women declined to take part in the trial.

1 woman in the CTG group had to be excluded from data analysis since all her records were mislaid before evaluation.

All women seemed to get their allocated Doppler or CTG, so this was an ITT analysis.

Selective reporting (reporting bias)

Unclear risk

All outcomes were described in results section, but we did not assess the trial protocol.

Other bias

High risk

The study was not stopped earlier.

Baseline imbalance:

  • significantly more operations (elective CS) due to breech presentation and suspected feto‐pelvic disproportion in the Doppler group;

  • the proportion of smokers was higher in the Doppler group than in the CTG group.

Differential diagnosis: Almstrom 1995 concluded that obstetricians may have been influenced by the knowledge of a normal umbilical Doppler examination when assessing the CTG in labour. This might have contributed bias to the finding of fewer emergency CS for fetal distress in the Doppler group than in the CTG group.

Biljan 1992

Methods

Randomised controlled study.

Participants

Women with high‐risk singleton pregnancies.

N = 674 women randomised.

Interventions

Intervention: Doppler of umbilical artery revealed. N = 338.

Comparison: no Doppler. N = 336.

Outcomes

Elective births; GA at birth; birthweight; Apgar scores, admissions to NICU, length of time in NICU, number of babies ventilated, length of ventilation, perinatal mortality.

Notes

The information came only from the 2 conference abstracts and personal communication (ZA). Sadly, Dr Biljan has died, so further detailed information on the study is not available. The information on the number of women randomised to each group was obtained from previous published version of this systematic review (Alfirevic 1995), and data on 'potentially preventable perineal deaths' was calculated from data in a previous version of this Cochrane review (Neilson 1996).

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

"...were randomised..."

Allocation concealment (selection bias)

Unclear risk

No information provided.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Insufficient information provided in the conference abstract to assess this.

Selective reporting (reporting bias)

High risk

Only gave data for the significant findings and reported the nonsignificant findings just as lower but not statistically significant.

Other bias

Unclear risk

Insufficient information provided in the conference abstract to assess this.

Burke 1992

Methods

Prospective RCT, individual women, 2 trial arms.

Participants

Women with high‐risk pregnancies (suspected IUGR, hypertensive disorders, previous baby < 2.5 kg, antepartum haemorrhage, previous perinatal death, diminished fetal movements, post maturity, diabetes, and others).

N = 476 women.

Interventions

Intervention: Doppler of umbilical artery and fetal biometry and BPP scoring.

Comparison: fetal biometry and BPP scoring.

Outcomes

Primary outcomes: induction of labour, elective and emergency CS, preterm delivery, and perinatal loss.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Randomisation by a random number sequence but it was unclear whether this was made by a third independent person.

Allocation concealment (selection bias)

Unclear risk

Sealed numbered envelopes but there was no information whether the envelopes were opaque and whether there was an ordered numbered sequence.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No exclusions after randomisation.

Reported as ITT.

Selective reporting (reporting bias)

Unclear risk

All outcomes were described in the results section, but we did not assess the trial protocol.

Other bias

Low risk

The study was not stopped early.

Baseline imbalance: "Doppler examinations were not carried out in the control group unless specifically requested by the consultant in charge of patients" ‐ 2 women in the control group had a Doppler and were not excluded.

De Rochambeau 1992

Methods

2‐arm RCT of individual women.

Participants

Women with singleton post‐term pregnancies (40 + 3 weeks to 42 + 3 weeks).

N = 107 women.

Interventions

Intervention: Doppler US of umbilical artery.

Comparison: no Doppler US, and standard care (FHR).

Outcomes

CS, RDS and post maturity.

Notes

Paper in French with English abstract, paper was translated. Most of the data were missing.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Women "...were randomly divided...".

No information on how the random sequence was generated.

Allocation concealment (selection bias)

Unclear risk

Not described.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Describe any loss of participants to follow‐up at each data collection point:     

  • none reported.

Describe any exclusion of participants after randomisation:

  • there appeared to be none.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • probably.

Selective reporting (reporting bias)

Unclear risk

There was no list of prespecified outcomes as far as we could ascertain and we did not assess the trial protocol.

Other bias

Unclear risk

If the study was stopped early, explain the reasons:

  • no.

Describe any baseline imbalance:

  • no information provided.

Describe any differential diagnosis:

  • unclear.

Giles 2003

Methods

Multi‐centred RCT; block randomisation, block of 20.

Individual women, 2‐arm trial.

Participants

Women with twin pregnancies (monochorionic and dichorionic) at 25 weeks. 2 viable apparently normally formed fetuses seen on US scan.

Exclusions: fetal anomalies; polyhydramnios/oligohydramnios; demise of 1 twin before 25 weeks.

Significance of chorionicity not realised at time randomisation began so no attempt was made to assess chorionicity.

N = 539 women.

Interventions

Intervention: Doppler and biometry US.

  • Doppler + biometry at 25, 30 and 35 weeks;

  • “the clinicians were advised to undertake interventions if there was an abnormal umbilical artery Doppler study (> 95th centile systolic diastolic ratio) or abnormal ultrasound biometry indicating discordant growth. The suggested intervention was intensive surveillance by obstetrics caregivers...if other indicators of fetal well‐being (lack of serial growth, decreased amniotic fluid or abnormal fetal monitoring) were abnormal, the early delivery was advised after 25 weeks;

  • “An abnormality of Doppler waveforms themselves was not considered an indication for immediate delivery unless there was absence of diastolic flow velocity at > 32 weeks of gestation”.

Comparison: biometry US.

  • Biometry only at 25, 30 and 35 weeks.

Outcomes

Maternal: antenatal admission, presence of hypertension, gestation at delivery, indication for delivery and mode of delivery.

Fetal: US biometry measurements, umbilical artery doppler systolic diastolic ratios and the occurrence of fetal death and causative factors.

Neonatal: birthweight, Apgar scores, admission to NICU, admission to special care nursery, requirements for ventilation and occurrence of neonatal death (up to 28 days of life).

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

“....opaque sealed envelopes containing the randomisation code the envelope being opened by an observer remote from patient care”.

Allocation concealment (selection bias)

Low risk

“....opaque sealed envelopes containing the randomisation code the envelope being opened by an observer remote from patient care".

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Describe any loss of participants to follow‐up at each data collection point:

  • 539 women were randomised in Doppler Assessment in Multiple Pregnancy (DAMP) study: Doppler 268 and control 271. 13 were lost to follow‐up after randomisation at 25 weeks and were not included in the results. This left 526 women with complete follow‐up: 262 in Doppler and 264 in no Doppler.                             

Describe any exclusion of participants after randomisation:

Was the analysis ITT? If not, have the data been able to be reincluded?

  • 7 women in the no Doppler group had Doppler.

Selective reporting (reporting bias)

Unclear risk

There seemed to be no evidence of selective reporting bias, but we did not assess the trial protocol.

Other bias

Low risk

If the study was stopped early, explain the reasons:

  • not stopped early, but PNM findings in study much lower than expected. Power calc was based on 85.7/1000 (but PNM in study was 11/1000), so study significantly underpowered ‐ needed 3300 per arm.

Describe any baseline imbalance:

  • no imbalances.

Haley 1997

Methods

2‐arm RCT with stratified block randomisation producing 4 groups: Caucasian primiparous and multiparous women, and Asian primiparous and multiparous women. Randomised in blocks of 8 using table of random numbers. However, the results are not reported by any of these subgroups ‐ only Doppler vs CTG overall.

Randomisation was of individual women.

Participants

Women with singleton fetuses with US examination showing the abdominal circumference < 2 SD of the mean for the GA FHR on charts recommended by British Medical Ultrasound Society. There was no GA constraint although all women were > 26 weeks' gestation.

N = 150 women.

Interventions

Intervention: Doppler of umbilical artery and no CTG.

Comparison: CTG.

Outcomes

Primary: duration of hospital antenatal admission, induction of labour rates.

Secondary: number of investigations (CTG or Doppler), number of outpatient visits to hospital, emergency CS rate, length of stay on the NICU, birthweight, and 1 min and 5 min Apgar score.

All women were sent a questionnaire asking their views on the process of their care.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Blocks of 8 using a table of random numbers.

Allocation concealment (selection bias)

Low risk

"...randomisation only possible by telephone .... sequentially numbered sealed opaque envelopes..."

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

No loss of participants at follow‐up.

No exclusion after the randomisation.

ITT analysis.

Selective reporting (reporting bias)

Unclear risk

We did not assess the trial protocol. Also, despite the stratified randomisation to look at ethnicity and parity, the results are not reported by any of these subgroups, only Doppler vs CTG overall.

Other bias

Low risk

Study went to completion.

Baseline imbalance: more women had no live‐in support at home in the CTG group.

Differential diagnosis: "...there was not a rigid protocol except that clinicians usually felt that a CTG record gave reassurance for 48 to 72 hours and a Doppler examination for a week or more ...".

Hofmeyr 1991

Methods

2‐arm RCT, but with additional evaluation by the nonallocated technique.

Randomisation was of individual women.

Participants

Women undergoing evaluation of fetal well‐being in the high‐risk obstetric unit. 867 women randomised.

N = 897 women.

Interventions

Intervention: Doppler US of umbilical artery.

Comparison: computerised CTG.

Outcomes

Number and duration of tests; perinatal outcomes.

“Our objective was to determine whether the experimental policy of Doppler study followed when necessary by FHR testing would take less time than routine FHR testing alone".

Notes

We contacted the authors to ask for clarification of the phrase, "computer generated algorithm based on the hospital number". They kindly responded with an explanation: "allocation was done automatically by a computer programme.  Although the algorithm made use of the woman's hospital number, it was impossible for the midwife performing the fetal assessment to predict to which group the women would be allocated. The 'algorithm' was simply a mathematical sequence which was applied to the woman's hospital number to generate an allocation".

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

"...computer generated algorithm based on the hospital number...". We sought clarification from the authors who kindly responded:

"allocation was done automatically by a computer programme".

Allocation concealment (selection bias)

Low risk

Not described in the paper but we wrote for clarification from the authors who kindly responded:

"although the algorithm made use of the woman's hospital number, it was impossible for the midwife performing the fetal assessment to predict to which group the women would be allocated. The 'algorithm' was simply a mathematical sequence which was applied to the woman's hospital number to generate an allocation".

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Describe any loss of participants to follow‐up at each data collection point:  

  • none apparent.                                                       

Describe any exclusion of participants after randomisation:

  • none apparent.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • it would appear so.

Selective reporting (reporting bias)

Unclear risk

There was no list of prespecified outcomes from the protocol, and we did not assess the trial protocol.

Other bias

High risk

If the study was stopped early, explain the reasons:

  • not stopped early as far as could ascertain.

Describe any baseline imbalance:

  • imbalance in numbers in each group: 439 Doppler vs 459 FHR;

  • unspecified number of women in CTG group had also Doppler evaluation ‐ assessment by the alternate nonallocated method was required on 1241 (66%) of 1869 occasions in which the allocated method was Doppler, and 804 (39%) of 2069 occasions when the allocated method was FHR testing.

Johnstone 1993

Methods

2‐arm RCT. Randomisation by Zelen method ‐ only those randomised to Doppler were invited to participate in the trial. Those allocated to CTG were being given normal care so their permission was regarded as not required.

Randomisation was of individual women.

Participants

Women with pregnancies identified clinically as being at increased risk (N = 2289 out of the 8018 women giving birth at the hospital during the time of the study).

Doppler or CTG or BPP was given to pregnant women where there was concern by medical staff about antenatal fetal well‐being by random allocation. Women were admitted to the trial if there was a wish for Doppler studies or a referral for AN fetal monitoring (CTG or BPP). So, all women meeting these criteria were randomised regardless of risk.

N = 2289 women.

Interventions

Intervention: Doppler US of umbilical artery (and other monitoring).

Comparison: no Doppler ‐ but other monitoring used (CTG/BPP).

Outcomes

Fetal mortality and morbidity; obstetric interventions; use of other tests of fetal monitoring; impact on obstetric decision making; health and personal costs; women’s satisfaction (to be presented in a separate report).

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Just described as randomised.

Allocation concealment (selection bias)

Low risk

“Sequentially numbered opaque sealed envelopes were attached by stapling to the case notes of all women attending this hospital. Randomisation was carried out by opening the envelope for every woman who met the criteria described above.”

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Describe any loss of participants to follow‐up at each data collection point:    

  • all women seemed to have data collected.

Describe any exclusion of participants after randomisation:

  • of the 1114 women allocated to Doppler, 24 did not have Doppler assessment (2%);

  • 3 women got 'Doppler' though they were randomised to 'no Doppler';

  • uneven, but numbers were small relative to the size of the study.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • “data analysis was on an ITT basis".

Selective reporting (reporting bias)

Unclear risk

They seemed to report on their prespecified outcomes but we did not assess the trial protocol.                                                           

Other bias

Low risk

If the study was stopped early, explain the reasons:

  • no.

Describe any baseline imbalance:

  • none reported in the text.

Describe any differential diagnosis:

  • seemed okay.

Receiving the other intervention:

  • 24 women allocated to Doppler did not have it performed;

  • 3 women in No Doppler had Doppler.

Lees 2013

Methods

3‐arm prospective randomised controlled study of individual women.

Participants

Study in 20 tertiary care hospitals in 5 European countries (Austria, Germay, Italy, The Netherlands, UK).

Women over 18 years capable of giving consent. Singleton pregnancy at 26 + 0 to 31 + 6 weeks’ gestation with FGR (defined as abdominal circumference below the 10th percentile based on local standards and abnormal umbilical artery Doppler pulsatility index (PI) above the 95th percentile based on local standards irrespective of the presence or absence of reversed end‐diastolic flow). In all cases, estimated fetal weight was > 500 g. Short‐term variation after 1 hour of CTG tracing had to be > 3.5 ms at 26 to 28 weeks and > 4 at 29 to 31 weeks with ductus venosus PI < 95th percentile. (GA determined by US at 14 and between 14 to 21 + 6 weeks).

Women with known or planned impending delivery, major structural abnormality or fetal karyotype abnormality were excluded.

N = 511 randomised (8 subsequently excluded).

Interventions

Randomisation groups:

1. Cardiotocograph short term variation (CTG STV) and timing of delivery was assessed with a criterion for reduced STV. Umbilical artery Doppler measurements were taken but no waveform measurements of the ductus venosus were recorded. (166 allocated, 21 lost to follow‐up, 1 missing neonatal data, 144 in primary analysis).

2. Early abnormality of ductus venosus prompted delivery (early changes pulsatility index > 95th percentile) (n = 167, 25 lost to follow‐up, 142 in primary analysis).

3. Late ductus venosus changes (a wave indicated no or reversed flow) (n = 170, 13 lost to follow‐up, 157 in primary analysis).

All measurements were confirmed by a second measurement at least 24 hours later. Monitoring in all groups included umbilical artery Doppler and CTG was recommended at least once a week but could be more frequent depending on local protocol. Irrespective of randomised group, there was a cutoff rescue value for STV based on CTG at 26 to 28.9 weeks that prompted delivery. At 32 weeks, deliveries were according to local protocol.

In all groups, delivery could be undertaken based on a maternal indication such as severe pre‐eclampsia or clear CTG abnormalities such as recurrent late decelerations.

Outcomes

Primary outcome: survival without cerebral palsy or neurosensory impairment, or a Bayley III developmental score of less than 85 at 2 years of age.

Secondary outcomes: composite of adverse neonatal outcome defined as fetal or postnatal death (between trial entry in‐utero and discharge home from neonatal services) or 1 or more of the following severe morbidities: BPD (defined as supplemental oxygen to maintain SATs > 90% at 36 weeks), severe cerebral haemorrhage (IVH grade III or IV) cystic periventricular leukomalacia, proven neonatal sepsis (blood culture and requiring antibiotics) or NEC (presence of pneumatosis or perforation on X‐ray or disease present on laparotomy).

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Through central randomisation website. Random block design, stratified by gestation (< 29 vs > 29 weeks) and centre.

Allocation concealment (selection bias)

Low risk

Through central randomisation website.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

It was not feasible to blind clinicians to intervention group. Women may have been aware of randomisation group.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Neonatal outcome data entered directly from records and entered into database.

Not possible to blind outcome assessment for all outcomes, however, the assessor of the primary outcome was blinded.

“Concealment of the allocated monitoring regime was not possible, and clinicians responsible for the care of the women entered in the study and women themselves were aware of the treatment allocation. However, the paediatrician doing the follow‐up examination was masked to follow‐up assessment and data entry allocation”.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Of 511 randomised, missing data for 8 women and babies for the primary outcome. There was some attrition at 2‐year follow‐up (59 lost to follow‐up).

ITT analysis.

Selective reporting (reporting bias)

Low risk

Protocol available and no evidence of outcome reporting bias.

Other bias

Low risk

Demographic data given for whole sample and those with poor composite outcome. Groups appeared similar at baseline.

Neales 1994 [pers comm]

Methods

2‐arm randomised controlled study of individual women.

Participants

Women of 24 weeks or greater gestation with a singleton pregnancy, and ultrasonic evidence of IUGR (abdominal circumference on or below 5th centile for GA).

N = 467 women.

Interventions

Intervention: Doppler US of umbilical artery revealed, weekly or more often if indicated. Documented in notes. Discussed with registrar.

Comparison: Doppler US weekly but recorded in separate file and not disclosed to clinicians.

Outcomes

Obstetric management: gestation at birth, time from enrolment to birth, mode of birth/onset of labour, fetal distress in labour.

Neonatal outcome: perinatal mortality, birthweight, admission to NICU, neonatal outcome.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information other than 'randomised'.

Allocation concealment (selection bias)

Unclear risk

Sealed envelopes but there was no information as to whether the envelopes were opaque and whether they were distributed in a sequential order.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Describe any loss of participants to follow‐up at each data collection point:   

  • no withdrawals reported.                                                          

Describe any exclusion of participants after randomisation: no exclusion:

  • no withdrawals reported.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • ITT as far as able to assess. Not specifically stated as such.

Selective reporting (reporting bias)

High risk

Not all outcomes available and we did not assess the trial protocol.

Other bias

Unclear risk

If the study was stopped early, explain the reasons:

  • not stopped early for benefit, but underpowered due to 'cannot do a large enough study'.

Newnham 1991

Methods

2‐arm RCT, stratified for twin pregnancies.

Randomisation was of individual women.

Participants

Women with high‐risk pregnancies, singletons and twins.

Defined as those disorders of pregnancy in which an increased risk of retarded fetal growth or impaired fetal well‐being were considered likely.

N = 505 women.

Interventions

Intervention: Doppler of umbilical and utero‐placental (within the placental bed) artery.

  • N = 254, including 21 twins.

  • Performed immediately after randomisation and then frequency by clinical judgement.

  • "The ratio of peak systolic (S) to least diastolic (D) Doppler shift frequency was calculated from waveforms obtained from an umbilical artery and from a maternal uteroplacental artery within the placental bed. These ratios were not adjusted to standard fetal or maternal heart rates”.

Comparison: no Doppler.

  • N = 251, including 19 twins.

Outcomes

Primary: duration of neonatal stay in hospital.

Secondary: number and type of fetal heart monitoring studies, obstetric interventions, frequency of fetal distress, birthweight, Apgar score, and need for NICU.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Just described as random.

Allocation concealment (selection bias)

Low risk

Numbered opaque sealed envelopes.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Assessors of neonatal outcomes were blind to Doppler results.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Describe any loss of participants to follow‐up at each data collection point:

  • no loss reported.                                                   

Describe any exclusion of participants after randomisation:

  • none described.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • apparently yes.

Selective reporting (reporting bias)

Unclear risk

Reported outcomes were the same as those prespecified but we did not assess the trial protocol.

Other bias

Low risk

If the study was stopped early, explain the reasons:

  • no.

Describe any baseline imbalance:

  • groups comparable for maternal age, height, parity, smoking and GA. No 'P' values given but looked alright.

Describe any differential diagnosis:

  • seemed alright.

Nienhuis 1997

Methods

Randomised controlled study ‐ stratified randomisation and block randomisation.

Stratification by GA (< 32 weeks and > 32 weeks) and smoking (regardless of number of cigarettes smoked).

Randomisation by individual women, 2‐arm trial.

Participants

Women with clinically suspected IUGR of > 2 weeks diagnosed by fundal height measurements at the outpatient clinic. Singleton pregnancies.

Exclusions: multiple pregnancies, uncertain GA, nonCaucasian origin, maternal or fetal conditional requiring immediate hospitalisation or intervention.

N = 161 women.

Interventions

Intervention: Doppler US of umbilical artery revealed:

  • done weekly until birth;

  • maintaining outpatient management while the Doppler was in the normal range, in a setting whereby hospitalisation was the management of choice where significant IUGR was suspected.

Comparison: Doppler US of umbilical artery concealed:

  • the PIs were not calculated until after birth and the results were concealed from the clinicians in charge;

  • standard clinical management for suspected IUGR.

Outcomes

Effect on costs in terms of hospitalisation, perinatal outcome, neurological development and postnatal catchup growth, onset and mode of birth, birthweight, and GA at birth.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

  • Randomised numbers from a published table of random numbers from a person not involved in patient management.

  • However, study stated “....even number allocated the participant to the intervention group....uneven numbers were allocated to the control group” (Nienhuis 1995).

  • A block size of 10 was used.

Allocation concealment (selection bias)

Low risk

  • “A randomisation number was requested over the telephone from an independent person not involved in patient management”.

  • After the stratification, the next number of 1 of the 4 randomisation lists was read.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Low risk

Assessors of neonatal outcomes were blind to Doppler results.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Describe any loss of participants to follow‐up at each data collection point:

  • 11 women refused to participate in the study.                                                          

Describe any exclusion of participants after randomisation:

  • 8 cases were excluded (4 in intervention group and 4 in control group) because of congenital defects.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • not for some outcomes ‐ not able to reinclude;

  • authors took out protocol violation and re‐evaluated because they said: “14 participants were admitted during pregnancy despite a normal Doppler. Suspected IUGR was the sole reason and they should not have been admitted. The authors recalculated excluding these 14 and this is inappropriate as it is likely to reflect real life".

Selective reporting (reporting bias)

Unclear risk

All the outcomes were reported but we did not assess the trial protocol.

Other bias

High risk

If the study was stopped early, explain the reasons: 

  • not reported as stopping early.

Describe any baseline imbalance:  

  • slight difference in primipara: Doppler 34/74 (46%) and control 43/76 (57%) but reported as NS;

  • 58.1% boys in intervention group and 36.8% boys in control group;

  • 4.1% breech in intervention group and 18.4% breech in control group;

  • in the analysis, the possible influence of the skewed distribution of sex was reduced by using sex‐specific growth reference.

Nimrod 1992

Methods

RCT; 2‐arm trial randomising individual women.

Participants

Pregnant women seen at the 'Fetal Assessment Unit' over 40 weeks' gestation.

Interventions

Intervention: pulsed Doppler revealed. Fetal aorta and umbilical artery assessed. BPP and NST also undertaken.

Comparison: pulsed Doppler concealed. BPP and NST were reported.

Outcomes

CS; gestation at birth; meconium in amniotic fluid; need for phototherapy.

Notes

Conference abstract available, but no full publication.

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

No information available.

Allocation concealment (selection bias)

Unclear risk

No information available.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

No information available.

Selective reporting (reporting bias)

Unclear risk

Very limited data in the conference abstract. We did not assess the trial protocol.

Other bias

Unclear risk

No information available on which to judge this aspect.

Norman 1992

Methods

RCT. Individual women randomised in 2 arms.

Participants

Women with high‐risk pregnancies with recurrent pregnancy loss (2 or more mid trimester or early third trimester losses which resulted in IUFD, stillbirth or neonatal death) at least 24 weeks' pregnant. 54 women randomised.

N = 54 women.

Interventions

Intervention: Doppler velocimetry of umbilical artery revealed.

Comparison: Doppler velocimetry of umbilical artery concealed.

Outcomes

Maternal intervention, hospital stay, induction of labour, CS, perinatal mortality and morbidity.

Notes

A conference poster (incomplete data).

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Women were randomly allocated.

Allocation concealment (selection bias)

Unclear risk

Sealed envelope, but no mention of how they were distributed nor whether they were opaque.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Describe any loss of participants to follow‐up at each data collection point:   

  • 1 woman lost to follow‐up, but no explanation.

Describe any exclusion of participants after randomisation:

  • no information.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • no information.

Selective reporting (reporting bias)

Unclear risk

No information in the poster to enable this to be assessed. Also we did not assess the trial protocol.

Other bias

Low risk

If the study was stopped early, explain the reasons:

  • was not stopped early.

Describe any baseline imbalance:

  • “...both groups were comparable at study entry as regards maternal age, number of previous losses and GA”.

Describe any differential diagnosis:

  • seemed fine.

Ott 1998

Methods

2‐arm RCT of individual women.

Participants

Women referred to the perinatal laboratory so high‐risk pregnancies (risk of UPI; fetal risk; postdates; maternal diabetes; PROM/PTL; fluid abnormalities).

N = 715 women.

Interventions

Intervention: fetal and umbilical Doppler + modified BPP.

Comparison: no Doppler but modified BPP.

Outcomes

Primary outcome: neonatal morbidity rate (admission to NICU, length of stay in NICU, significant neonatal morbidity).

Secondary outcome: GA at delivery, neonatal weight, CS for fetal distress.

Notes

The outcome of 'significant neonatal morbidity' assessed in this study included central nervous system complications, sepsis, acidosis/asphyxia, cardiomyopathy, anaemia, metabolic outcomes but excluded RDS. Anaemia and metabolic outcomes were not defined. We considered this outcome to be sufficiently different from the review's primary outcome of 'serious neonatal morbidity (composite outcome including hypoxic ischaemic encephalopathy, IVH, BPD, NEC)' that we did not include these data in the meta‐analysis. This study found no significant difference in 'significant neonatal complications' between the Doppler group (8%) and the no Doppler group (6.6%).

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

“Computer‐generated random number allocation system.”

Allocation concealment (selection bias)

Unclear risk

No information provided.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Describe any loss of participants to follow‐up at each data collection point:   

  • 20.5% participants refused to participate in the study;

  • 50/715 participants (7.0%) withdrew from the study ‐ delivered at another institution or were lost to follow‐up;

  • 37 (11.7%) women in control arm had Doppler US at physician's request.

Describe any exclusion of participants after randomisation:

  • see above. 

Was the analysis ITT? If not, have the data been able to be reincluded?

  • no, not ITT. It was not reported how many women were randomised to each group, only given how many analysed in each group and this had to be calculated from the information on reasons for testing in Table 2.

Selective reporting (reporting bias)

Unclear risk

Although the prespecified outcomes in the paper were reported. we were not able to assess the protocol, so are not sure whether there was outcome reporting bias. The authors reported only on CS for fetal distress, and not on all CS.                                                            

Other bias

Low risk

If the study was stopped early, explain the reasons:

  • no, not stopped early.

Describe any baseline imbalance:

  • seemed that the groups were balanced.

Describe any differential diagnosis:

  • 37 (11.7%) women in control arm had Doppler US at physician’s request.

Pattinson 1994

Methods

RCT; block randomisation of individual women:

  • 2‐arm RCT but with 3 subgroups: group 1. women with fetuses with AEDV; group 2: women with hypertension but fetuses with EDV and group 3: women with fetuses suspected of being SGA but with EDV present;

  • 3 groups were created based on clinical picture and Doppler results;

  • if the woman was hypertensive and fetus had EDV and was suspected of being small, then she went to HT group;

  • each subset was managed differently;

  • balanced block randomisation in blocks of 10 for AEDV and 20 for other groups. There were equal numbers of women in each group;

  • data analysed at completion of each block;

  • in each group, Doppler revealed and Doppler concealed.

Participants

Women > 28 weeks' pregnant with hypertension and/or suspected SGA fetuses were referred for Doppler US. 212 women with singleton pregnancies.

N = 212 women.

Interventions

Intervention: Doppler velocimetry of umbilical artery revealed:

  • other tests available, e.g. sonar and AN FHR.

Comparison: Doppler velocimetry of umbilical artery concealed:

  • other test available, e.g. sonar and AN FHR.

Outcomes

Perinatal mortality and morbidity, antenatal hospitalisation, maternal intervention, admission to the NICU, and hospitalisation until discharge from the neonatal wards.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

“...randomisation was performed by the person doing the Doppler velocity .......”

Allocation concealment (selection bias)

Unclear risk

“......opaque sealed envelopes......”, but no mention of numbered and sequentially ordered envelopes.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Describe any loss of participants to follow‐up at each data collection point:    

  • none were lost.

Describe any exclusion of participants after randomisation:

  • not apparent.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • probably.

Selective reporting (reporting bias)

Unclear risk

All the outcomes were reported but we did not assess the trial protocol.

Other bias

High risk

If the study was stopped early, explain the reasons:

  • in the group of AEDV (20 women), there were 6 perinatal deaths in the control group and 1 perinatal death in the study group. The trial was stopped at this point because significantly more fetuses had died in the control group.

Describe any differential diagnosis:

  • if AEDF detected, then Doppler was repeated the following day. In the control group, Doppler was repeated weekly if the woman was in hospital and fortnightly if the woman was an outpatient;

  • in the AEDV group, the authors stated that "by giving the responsible clinician a management guideline for a fetus with ADEV we might have biased the outcome because the clinician was aware we were specifically interested in the outcome and so more care might have been taken";

  • women in the control group were managed by consultants who might have had an infertility or gynaecology speciality, where women with problems identified were managed with a specific management plan. So it is possible that there might not have been a difference in a hospital where all high‐risk pregnancies were managed by clinicians who were subspecialists in perinatal medicine.

Trudinger 1987

Methods

2‐arm RCT of Individual women.

Participants

Women with high fetal risk (singletons). More than 28 weeks' gestation.

N = 300 women.

Interventions

Intervention: Doppler of umbilical artery revealed:

  • full access to other methods of fetal assessment, e.g. fetal movements chart, CTG, US measurements and imaging, maternal estrogens, placental lactogens.

Comparison: Doppler of umbilical artery concealed:

  • full access to other methods of fetal assessment e.g. fetal movements chart, CTG, US measurements and imaging, maternal estrogens, placental lactogens.

Outcomes

Perinatal mortality, CS, induction of labour, etc.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

Random number though no information on how they were generated and by whom.

Allocation concealment (selection bias)

Unclear risk

“Each patient was asked to draw an envelope containing a random number and those with even numbers were allocated to the Doppler report available group”.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Low risk

Describe any loss of participants to follow‐up at each data collection point:  

  • 11 women gave birth at other hospitals (6 Doppler and 5 controls) ‐ left Doppler with 127 women and control with 162 women.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • available case analysis.

Selective reporting (reporting bias)

Unclear risk

No outcome listed in methods section and we did not assess the trial protocol. 

Other bias

Low risk

If the study was stopped early, explain the reasons:

  • not stopped.

Describe any baseline imbalance:

  • fine.

Describe any differential diagnosis:

  • seemed OK.

Tyrrell 1990

Methods

RCT; pragmatic 2‐arm trial.

Participants

Women with high‐risk singleton pregnancies.

Specifically, 500 pregnant women at high risk of growth retardation or stillbirth. IUGR clinically suspected or by US scan, previous SGA baby, previous antepartum haemorrhage, hypertension.

Exclusions: women with diabetes, twin pregnancies.

N = 500 women.

Interventions

Intervention: routine use of Doppler and BPP testing + other tests:

  • Doppler of umbilical and uteroplacental arteries;

  • testing at 28 weeks' gestation, or at the time of presentation if risk factors appeared later than this. Thereafter, they had weekly Doppler and fetal biophysical assessment for 3 weeks, followed by fortnightly examinations until delivery.

Comparison: no Doppler and no biophysical assessment but other tests only:

  • "clinicians responsible for the care of women in the selectively investigated arm could only obtain Doppler and biophysical assessment on special request, and this happened in only 12 pregnancies”.

Outcomes

Total number of days of antenatal admission, rate of induction of labour (by any method), mode of birth (elective CS and emergency CS), 1 and 5 min Apgar, birthweight, admission to NICU.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Unclear risk

  • "...random number sequence...” though it is not clear how this was generated;

  • "...the randomisation was performed by the 2 ultrasonographers involved in the study neither of whom knew anything about the patients or was involved in their clinical management...".

Allocation concealment (selection bias)

Unclear risk

  • "...sealed, sequentially numbered envelopes..” though it is not clear whether these were opaque.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Describe any loss of participants to follow‐up at each data collection point:

  • "...the data on duration of antenatal stay and induction of labour were obtained retrospectively, and the case notes could not be traced in 15% of the women".

Describe any exclusion of participants after randomisation:

  • no exclusion.

Was the analysis ITT? If not, have the data been able to be reincluded?

  • 12 women in 'no Doppler' group had Doppler and BPP at specific request of obstetrician. These seemed to be assessed in the group to which women were randomised, so appeared to be ITT.

Selective reporting (reporting bias)

Unclear risk

Not all outcomes were reported, emergency CS just reported in the text. We did not assess the trial protocol.

Other bias

Unclear risk

If the study was stopped early, explain the reasons:

  • not reported;

  • the registered study aimed for 28,000 over 7 years, but this was probably impractical.

Describe any baseline imbalance:

  • "clinicians responsible for the care of women in the selectively investigated arm could only obtain Doppler and biophysical assessment on special request, and this happened in only 12 pregnancies".

Describe any differential diagnosis:

  • seemed alright.

Williams 2003

Methods

Randomised controlled study; block randomisation (block of 4 and 6).

Individual women.

Participants

Women with high‐risk pregnancies: singletons (IUGR 7%, hypertension 10%, diabetes 11%, prolonged pregnancy 43%, decreased fetal movements 22%). GA > 32 weeks.

N = 1360 women.

Interventions

Intervention: umbilical artery Doppler:

  • if Doppler normal, then women seen twice a week; if equivocal, then amniotic fluid index done; if abnormal, then proceeded to induction/delivery within 24 hours.

Comparison: electronic FHR with NST:

  • twice a week; Kulbi score (5 components). If equivocal (identified Kulbi = 6), then assessment of amniotic fluid volume; if abnormal (identified Kulbi = 4), then induction/delivery within 24 hours.

Outcomes

Primary outcome: incidence of CS for fetal distress in labour (nonreassuring FHR).

Secondary outcome: total CS, Apgar score 1 and 5 min, the incidence of stillbirth, the presence of meconium, and the incidence of transfer to the NICU with severe neonatal morbidity.

Notes

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence generation (selection bias)

Low risk

Random number table with a variable block size of 4 and 6.

Allocation concealment (selection bias)

Unclear risk

Sequentially numbered opaque envelopes although no information as to whether they were sealed.

“...envelopes were kept in a locked drawer that was accessible only to the unit clerk. The envelops was opened by the nurse/sonographer in the presence of the patient”.

Blinding of participants and personnel (performance bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Blinding of outcome assessment (detection bias)
All outcomes

Unclear risk

Blinding women and/or staff in these trials was not generally feasible.

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

Describe any loss of participants to follow‐up at each data collection point:

  • no final outcome data were available for 16 women (10 in NST group and 6 in Doppler group).                                                     

Describe any exclusion of participants after randomisation:

  • 4 women were assigned in error, did not have the identified high‐risk condition, and were removed from further analysis; 1356 women in study.

Was the analysis ITT?

  • “once assigned randomly to particular group, the patient remained in that group for any subsequent assessment that took place in that pregnancy".

Selective reporting (reporting bias)

Unclear risk

All the outcomes were reported but we did not assess the trial protocol.

Other bias

Low risk

If the study was stopped early, explain the reasons:

  • study not stopped early for benefit.

Describe any baseline imbalance:

  • this seemed fine.

Describe any differential diagnosis:

  • this seemed alright.

AEDF: absent end diastolic flow
AEDV: absent end diastolic velocity
AN: antenatal
BPD: bronchopulmonary dysplasia
BPP: biophysical profile
CS: caesarean section
CTG: cardiotocography

D:
EDV: end diastolic velocities
FHR: fetal heart rate
GA: gestational age

HT:
ITT: intention‐to‐treat
IUFD: intrauterine fetal death
IUGR: intrauterine growth retardation
IVH: intraventricular haemorrhage
min: minute
NEC: necrotising enterocolitis
NICU: neonatal intensive care unit
NS: not significant
NST: nonstress test
PNM:

PTL: preterm labour
PROM: preterm rupture of membranes
RCT: randomised controlled trial
RDS: respiratory distress syndrome

S:

SAT:
SD: standard deviation
SGA: small‐for‐gestational age

STV:

UPI:
US: ultrasound
vs: versus

Characteristics of excluded studies [ordered by study ID]

Jump to:

Study

Reason for exclusion

Davies 1992

Participants were an "unselected population".

Gonsoulin 1991

Full report not available.

Mason 1993

Participants were "low‐risk primigravid women".

McCowan 1996

Conference abstract only but outcomes were comparing women with normal and abnormal Doppler ultrasound readings, so not a randomised comparison.

McParland 1988

This study was never reported in full although it has been partly reported in a review article (McParland 1988) and a full manuscript was given to the review authors by Dr Pearce, who has been accused of publishing reports of trials whose veracity cannot be confirmed (BJOG 1995). Consequently, the Doppler trial data are not now thought by the review authors to be sufficiently reliable to be retained within this review. 

Newnham 1993

Participants were an "unselected population".

Omtzigt 1994

Participants were a "non‐selected University Hospital population".

Pearce 1992

Dr Pearce has been accused of publishing reports of trials whose veracity cannot be confirmed (BJOG 1995). Consequently, the Doppler trial data are not now thought by the reviewers to be sufficiently reliable to be retained within this review. 

Schneider 1992

Participants were an "unselected pregnant population".

Whittle 1994

Participants were an "unselected population".

Data and analyses

Open in table viewer
Comparison 1. Umbilical artery Doppler ultrasound versus no Doppler ultrasound

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

16

10225

Risk Ratio (M‐H, Fixed, 95% CI)

0.71 [0.52, 0.98]

Analysis 1.1

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 1 Any perinatal death after randomisation.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 1 Any perinatal death after randomisation.

1.1 Singleton pregnancy

9

4661

Risk Ratio (M‐H, Fixed, 95% CI)

0.59 [0.35, 1.01]

1.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.32, 2.41]

1.3 Singleton plus multiple pregnancies, or not stated

6

4512

Risk Ratio (M‐H, Fixed, 95% CI)

0.78 [0.51, 1.19]

2 Serious neonatal morbidity Show forest plot

3

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

Analysis 1.2

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 2 Serious neonatal morbidity.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 2 Serious neonatal morbidity.

2.1 Singleton pregnancy

1

500

Risk Ratio (M‐H, Random, 95% CI)

0.13 [0.02, 0.99]

2.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.3 Singleton plus multiple pregnancies, or not stated

2

598

Risk Ratio (M‐H, Random, 95% CI)

2.95 [0.31, 28.14]

3 Stillbirth Show forest plot

15

9560

Risk Ratio (M‐H, Fixed, 95% CI)

0.65 [0.41, 1.04]

Analysis 1.3

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 3 Stillbirth.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 3 Stillbirth.

3.1 Singleton pregnancy

8

3996

Risk Ratio (M‐H, Fixed, 95% CI)

0.61 [0.31, 1.19]

3.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.67 [0.11, 4.00]

3.3 Singleton plus multiple pregnancy, or not stated

6

4512

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.35, 1.39]

4 Neonatal death Show forest plot

13

8167

Risk Ratio (M‐H, Fixed, 95% CI)

0.81 [0.53, 1.24]

Analysis 1.4

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 4 Neonatal death.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 4 Neonatal death.

4.1 Singleton pregnancy

7

2656

Risk Ratio (M‐H, Fixed, 95% CI)

0.69 [0.31, 1.53]

4.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.29, 3.46]

4.3 Singleton plus multiple pregnancies, or not stated

5

4459

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.48, 1.45]

5 Any potentially preventable perinatal death* Show forest plot

16

10225

Risk Ratio (M‐H, Fixed, 95% CI)

0.67 [0.46, 0.98]

Analysis 1.5

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 5 Any potentially preventable perinatal death*.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 5 Any potentially preventable perinatal death*.

5.1 Singleton pregnancy

9

4661

Risk Ratio (M‐H, Fixed, 95% CI)

0.58 [0.30, 1.13]

5.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.32, 2.41]

5.3 Singleton plus multiple pregnancies or not stated

6

4512

Risk Ratio (M‐H, Fixed, 95% CI)

0.69 [0.41, 1.15]

6 Apgar < 7 at 5 minutes Show forest plot

7

6321

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.69, 1.24]

Analysis 1.6

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 6 Apgar < 7 at 5 minutes.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 6 Apgar < 7 at 5 minutes.

6.1 Singleton pregnancy

4

2555

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.45, 1.09]

6.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.3 Singleton plus multiple pregnancies or not stated

3

3766

Risk Ratio (M‐H, Fixed, 95% CI)

1.16 [0.77, 1.73]

7 Caesarean section (elective and emergency) Show forest plot

14

7918

Risk Ratio (M‐H, Fixed, 95% CI)

0.90 [0.84, 0.97]

Analysis 1.7

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 7 Caesarean section (elective and emergency).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 7 Caesarean section (elective and emergency).

7.1 Singleton pregnancy

7

2929

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.75, 0.95]

7.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.77, 1.19]

7.3 Singleton plus multiple pregnancies or not stated

6

4463

Risk Ratio (M‐H, Fixed, 95% CI)

0.94 [0.84, 1.05]

8 Caesarean section ‐ elective Show forest plot

11

6627

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.93, 1.22]

Analysis 1.8

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 8 Caesarean section ‐ elective.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 8 Caesarean section ‐ elective.

8.1 Singleton pregnancy

6

1934

Risk Ratio (M‐H, Fixed, 95% CI)

1.11 [0.90, 1.38]

8.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.77, 1.47]

8.3 Singleton plus multiple pregnancies or not stated

4

4167

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.84, 1.26]

9 Caesarean section ‐ emergency Show forest plot

10

6175

Risk Ratio (M‐H, Random, 95% CI)

0.81 [0.67, 0.98]

Analysis 1.9

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 9 Caesarean section ‐ emergency.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 9 Caesarean section ‐ emergency.

9.1 Singleton pregnancy

5

1482

Risk Ratio (M‐H, Random, 95% CI)

0.58 [0.43, 0.78]

9.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Random, 95% CI)

0.84 [0.57, 1.23]

9.3 Singleton plus multiple pregnancies or not stated

4

4167

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.77, 1.20]

10 Spontaneous vaginal birth Show forest plot

5

2504

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.98, 1.10]

Analysis 1.10

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 10 Spontaneous vaginal birth.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 10 Spontaneous vaginal birth.

10.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.96, 1.18]

10.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.90, 1.19]

10.3 Singleton plus multiple pregnancies or not stated

2

1402

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.95, 1.12]

11 Operative vaginal birth Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.80, 1.14]

Analysis 1.11

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 11 Operative vaginal birth.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 11 Operative vaginal birth.

11.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.78, 1.22]

11.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.68, 1.25]

12 Induction of labour Show forest plot

10

5633

Risk Ratio (M‐H, Random, 95% CI)

0.89 [0.80, 0.99]

Analysis 1.12

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 12 Induction of labour.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 12 Induction of labour.

12.1 Singleton pregnancy

5

1784

Risk Ratio (M‐H, Random, 95% CI)

0.79 [0.64, 0.97]

12.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Random, 95% CI)

1.10 [0.80, 1.50]

12.3 Singleton plus multiple pregnancies or not stated

4

3323

Risk Ratio (M‐H, Random, 95% CI)

0.95 [0.86, 1.04]

13 Infant requiring intubation/ventilation Show forest plot

6

3136

Risk Ratio (M‐H, Random, 95% CI)

1.42 [0.87, 2.30]

Analysis 1.13

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 13 Infant requiring intubation/ventilation.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 13 Infant requiring intubation/ventilation.

13.1 Singleton pregnancy

4

1539

Risk Ratio (M‐H, Random, 95% CI)

2.89 [1.40, 5.96]

13.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Random, 95% CI)

0.86 [0.59, 1.25]

13.3 Singleton plus multiple pregnancies or not stated

1

545

Risk Ratio (M‐H, Random, 95% CI)

1.25 [0.79, 1.98]

14 Neonatal fitting/seizures Show forest plot

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.01, 8.49]

Analysis 1.14

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 14 Neonatal fitting/seizures.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 14 Neonatal fitting/seizures.

14.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.01, 8.49]

14.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

14.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15 Preterm labour Show forest plot

2

626

Risk Ratio (M‐H, Fixed, 95% CI)

1.12 [0.72, 1.75]

Analysis 1.15

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 15 Preterm labour.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 15 Preterm labour.

15.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.51, 2.07]

15.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15.3 Singleton plus multiple pregnancy or not stated

1

476

Risk Ratio (M‐H, Fixed, 95% CI)

1.18 [0.66, 2.11]

16 Gestational age at birth (weeks) Show forest plot

8

4066

Mean Difference (IV, Random, 95% CI)

0.21 [‐0.02, 0.43]

Analysis 1.16

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 16 Gestational age at birth (weeks).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 16 Gestational age at birth (weeks).

16.1 Singleton pregnancy

3

1043

Mean Difference (IV, Random, 95% CI)

0.54 [‐0.00, 1.09]

16.2 Multiple pregnancy

1

1052

Mean Difference (IV, Random, 95% CI)

0.10 [‐0.24, 0.44]

16.3 Singleton plus multiple pregnancies or not stated

4

1971

Mean Difference (IV, Random, 95% CI)

0.06 [‐0.19, 0.31]

17 Infant respiratory distress syndrome (RDS) Show forest plot

1

107

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.07, 16.48]

Analysis 1.17

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 17 Infant respiratory distress syndrome (RDS).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 17 Infant respiratory distress syndrome (RDS).

17.1 Singleton pregnancy

1

107

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.07, 16.48]

17.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18 Neonatal admission to SCBU and/or NICU Show forest plot

12

9334

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.89, 1.03]

Analysis 1.18

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 18 Neonatal admission to SCBU and/or NICU.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 18 Neonatal admission to SCBU and/or NICU.

18.1 Singleton pregnancy

8

4511

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.80, 1.06]

18.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.88, 1.05]

18.3 Singleton plus multiple pregnancies or not stated

3

3771

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.85, 1.14]

19 Hypoxic ischaemic encephalopathy Show forest plot

2

1045

Risk Ratio (M‐H, Random, 95% CI)

0.65 [0.01, 33.07]

Analysis 1.19

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 19 Hypoxic ischaemic encephalopathy.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 19 Hypoxic ischaemic encephalopathy.

19.1 Singleton pregnancy

1

500

Risk Ratio (M‐H, Random, 95% CI)

0.09 [0.01, 1.64]

19.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

19.3 Singleton plus multiple pregnancies or not stated

1

545

Risk Ratio (M‐H, Random, 95% CI)

4.91 [0.24, 101.79]

20 Intraventricular haemorrhage Show forest plot

4

2008

Risk Ratio (M‐H, Fixed, 95% CI)

1.42 [0.47, 4.30]

Analysis 1.20

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 20 Intraventricular haemorrhage.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 20 Intraventricular haemorrhage.

20.1 Singleton pregnancy

3

1463

Risk Ratio (M‐H, Fixed, 95% CI)

1.26 [0.38, 4.16]

20.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.3 Singleton plus multiple pregnancies or not stated

1

545

Risk Ratio (M‐H, Fixed, 95% CI)

2.95 [0.12, 71.99]

21 Birthweight (grams) Show forest plot

7

3887

Mean Difference (IV, Fixed, 95% CI)

31.33 [‐8.70, 71.37]

Analysis 1.21

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 21 Birthweight (grams).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 21 Birthweight (grams).

21.1 Singleton pregnancy

3

1916

Mean Difference (IV, Fixed, 95% CI)

49.34 [‐0.62, 99.31]

21.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.3 Singleton plus multiple pregnancies or not stated

4

1971

Mean Difference (IV, Fixed, 95% CI)

‐0.95 [‐67.84, 65.95]

22 Length of infant hospital stay (days) Show forest plot

3

1076

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.28 [‐0.40, ‐0.16]

Analysis 1.22

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 22 Length of infant hospital stay (days).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 22 Length of infant hospital stay (days).

22.1 Singleton pregnancy

3

1076

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.28 [‐0.40, ‐0.16]

22.2 Multiple pregnancy

0

0

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.3 Singleton plus multiple pregnancies or not stated

0

0

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

23 Birth < 34 weeks (not prespecified) Show forest plot

2

976

Risk Ratio (M‐H, Random, 95% CI)

2.04 [0.62, 6.69]

Analysis 1.23

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 23 Birth < 34 weeks (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 23 Birth < 34 weeks (not prespecified).

23.1 Singleton pregnancy

1

500

Risk Ratio (M‐H, Random, 95% CI)

1.17 [0.40, 3.42]

23.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

23.3 Singleton plus multiple pregnancies or not stated

1

476

Risk Ratio (M‐H, Random, 95% CI)

3.90 [1.11, 13.65]

24 Antenatal admissions (not prespecified) Show forest plot

2

893

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.60, 0.88]

Analysis 1.24

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 24 Antenatal admissions (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 24 Antenatal admissions (not prespecified).

24.1 Singleton pregnancy

2

893

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.60, 0.88]

24.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25 Phototherapy for neonatal jaundice (not prespecified) Show forest plot

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.87]

Analysis 1.25

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 25 Phototherapy for neonatal jaundice (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 25 Phototherapy for neonatal jaundice (not prespecified).

25.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.87]

25.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26 Abnormal neurological development at 9 months (not prespecified) Show forest plot

1

137

Risk Ratio (M‐H, Fixed, 95% CI)

0.61 [0.26, 1.45]

Analysis 1.26

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 26 Abnormal neurological development at 9 months (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 26 Abnormal neurological development at 9 months (not prespecified).

26.1 Singleton pregnancy

1

137

Risk Ratio (M‐H, Fixed, 95% CI)

0.61 [0.26, 1.45]

26.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27 Hospitalisation for IUGR neonatal (not prespecified) Show forest plot

1

142

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.75, 1.41]

Analysis 1.27

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 27 Hospitalisation for IUGR neonatal (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 27 Hospitalisation for IUGR neonatal (not prespecified).

27.1 Singleton pregnancy

1

142

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.75, 1.41]

27.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28 Fetal distress in labour (not prespecified) Show forest plot

1

289

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.10, 1.22]

Analysis 1.28

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 28 Fetal distress in labour (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 28 Fetal distress in labour (not prespecified).

28.1 Singleton pregnancy

1

289

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.10, 1.22]

28.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29 Birthweight < 5 percentile (not prespecified) Show forest plot

1

289

Risk Ratio (M‐H, Fixed, 95% CI)

1.16 [0.51, 2.64]

Analysis 1.29

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 29 Birthweight < 5 percentile (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 29 Birthweight < 5 percentile (not prespecified).

29.1 Singleton pregnancy

1

289

Risk Ratio (M‐H, Fixed, 95% CI)

1.16 [0.51, 2.64]

29.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30 Periventricular leucomalacia (not prespecified) Show forest plot

1

545

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.01, 8.00]

Analysis 1.30

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 30 Periventricular leucomalacia (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 30 Periventricular leucomalacia (not prespecified).

30.1 Singleton pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.3 Singleton plus multiple pregnancies or not stated

1

545

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.01, 8.00]

31 Antenatal hospital stay (days) (not prespecified) Show forest plot

1

426

Mean Difference (IV, Fixed, 95% CI)

‐0.60 [‐2.39, 1.19]

Analysis 1.31

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 31 Antenatal hospital stay (days) (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 31 Antenatal hospital stay (days) (not prespecified).

31.1 Singleton pregnancy

1

426

Mean Difference (IV, Fixed, 95% CI)

‐0.60 [‐2.39, 1.19]

31.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.3 Singleton plus multiple pregnancies or not stated

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Open in table viewer
Comparison 2. Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

6

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 2.1

Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups), Outcome 1 Any perinatal death after randomisation.

Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups), Outcome 1 Any perinatal death after randomisation.

1.1 SGA/IUGR

5

1292

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.38, 1.35]

1.2 Hypertension/pre‐eclampsia

1

89

Risk Ratio (M‐H, Fixed, 95% CI)

3.57 [0.42, 30.73]

1.3 Diabetes

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.4 Prolonged pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.5 Previous pregnancy loss

1

53

Risk Ratio (M‐H, Fixed, 95% CI)

0.26 [0.03, 2.17]

2 Serious neonatal morbidity Show forest plot

1

53

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

Analysis 2.2

Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups), Outcome 2 Serious neonatal morbidity.

Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups), Outcome 2 Serious neonatal morbidity.

2.1 SGA/IUGR

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.2 Hypertension/pre‐eclampsia

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.3 Diabetes

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.4 Prolonged pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.5 Previous pregnancy loss

1

53

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

Open in table viewer
Comparison 3. Umbilical artery Doppler ultrasound alone versus CTG alone

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.45 [0.17, 1.15]

Analysis 3.1

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 1 Any perinatal death after randomisation.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 1 Any perinatal death after randomisation.

1.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.07, 1.68]

1.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.52 [0.16, 1.73]

2 Stillbirth Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.48 [0.14, 1.71]

Analysis 3.2

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 2 Stillbirth.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 2 Stillbirth.

2.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.28 [0.05, 1.70]

2.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

2.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

1.05 [0.15, 7.41]

3 Neonatal death Show forest plot

3

1473

Risk Ratio (M‐H, Fixed, 95% CI)

0.52 [0.16, 1.72]

Analysis 3.3

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 3 Neonatal death.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 3 Neonatal death.

3.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.15, 7.10]

3.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.07, 1.72]

4 Any potentially preventable perinatal death* Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.38 [0.12, 1.18]

Analysis 3.4

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 4 Any potentially preventable perinatal death*.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 4 Any potentially preventable perinatal death*.

4.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.41 [0.08, 2.11]

4.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.07, 1.72]

5 Apgar < 7 at 5 minutes Show forest plot

3

2663

Risk Ratio (M‐H, Fixed, 95% CI)

0.86 [0.54, 1.37]

Analysis 3.5

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 5 Apgar < 7 at 5 minutes.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 5 Apgar < 7 at 5 minutes.

5.1 Singleton pregnancy

2

1766

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.49, 1.43]

5.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.36, 2.39]

6 Caesarean section (elective and emergency) Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.79, 1.01]

Analysis 3.6

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 6 Caesarean section (elective and emergency).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 6 Caesarean section (elective and emergency).

6.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.77, 1.02]

6.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.73, 1.14]

7 Caesarean section ‐ elective Show forest plot

3

1473

Risk Ratio (M‐H, Fixed, 95% CI)

1.53 [1.12, 2.09]

Analysis 3.7

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 7 Caesarean section ‐ elective.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 7 Caesarean section ‐ elective.

7.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.69 [1.07, 2.67]

7.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

1.40 [0.91, 2.15]

8 Caesarean section ‐ emergency Show forest plot

3

1473

Risk Ratio (M‐H, Fixed, 95% CI)

0.66 [0.52, 0.84]

Analysis 3.8

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 8 Caesarean section ‐ emergency.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 8 Caesarean section ‐ emergency.

8.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

0.55 [0.36, 0.83]

8.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.73 [0.55, 0.98]

9 Spontaneous vaginal birth Show forest plot

2

1323

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.97, 1.15]

Analysis 3.9

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 9 Spontaneous vaginal birth.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 9 Spontaneous vaginal birth.

9.1 Singleton pregnancy

1

426

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.91, 1.19]

9.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.95, 1.19]

10 Operative vaginal birth Show forest plot

3

2663

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.81, 1.17]

Analysis 3.10

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 10 Operative vaginal birth.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 10 Operative vaginal birth.

10.1 Singleton pregnancy

2

1766

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.80, 1.27]

10.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

10.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.68, 1.25]

11 Induction of labour Show forest plot

2

576

Risk Ratio (M‐H, Random, 95% CI)

0.67 [0.32, 1.40]

Analysis 3.11

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 11 Induction of labour.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 11 Induction of labour.

11.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Random, 95% CI)

0.67 [0.32, 1.40]

11.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

11.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

12 Infant requiring intubation/ventilation Show forest plot

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.54 [0.26, 9.08]

Analysis 3.12

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 12 Infant requiring intubation/ventilation.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 12 Infant requiring intubation/ventilation.

12.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.54 [0.26, 9.08]

12.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13 Neonatal fitting/seizures Show forest plot

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.01, 8.49]

Analysis 3.13

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 13 Neonatal fitting/seizures.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 13 Neonatal fitting/seizures.

13.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.01, 8.49]

13.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

14 Gestational age at birth Show forest plot

3

1473

Mean Difference (IV, Fixed, 95% CI)

0.23 [‐0.00, 0.47]

Analysis 3.14

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 14 Gestational age at birth.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 14 Gestational age at birth.

14.1 Singleton pregnancy

2

576

Mean Difference (IV, Fixed, 95% CI)

0.26 [‐0.06, 0.59]

14.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

14.3 Singleton plus multiple pregnancies or not stated

1

897

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐0.15, 0.55]

15 Neonatal admission to SCBU and/or NICU Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.73, 1.03]

Analysis 3.15

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 15 Neonatal admission to SCBU and/or NICU.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 15 Neonatal admission to SCBU and/or NICU.

15.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.80 [0.64, 0.99]

15.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

1.00 [0.73, 1.37]

16 Infant birthweight (grams) Show forest plot

4

2813

Mean Difference (IV, Fixed, 95% CI)

38.41 [‐6.14, 82.97]

Analysis 3.16

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 16 Infant birthweight (grams).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 16 Infant birthweight (grams).

16.1 Singleton pregnancy

3

1916

Mean Difference (IV, Fixed, 95% CI)

49.34 [‐0.62, 99.31]

16.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

16.3 Singleton plus multiple pregnancies or not stated

1

897

Mean Difference (IV, Fixed, 95% CI)

‐4.0 [‐102.42, 94.42]

17 Length of infant hospital stay (days) Show forest plot

2

576

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.25 [‐0.41, ‐0.08]

Analysis 3.17

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 17 Length of infant hospital stay (days).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 17 Length of infant hospital stay (days).

17.1 Singleton pregnancy

2

576

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.25 [‐0.41, ‐0.08]

17.2 Multiple pregnancy

0

0

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.3 Singleton plus multiple pregnancies or not stated

0

0

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

18 Antenatal admissions (not prespecified) Show forest plot

1

426

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.55, 0.90]

Analysis 3.18

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 18 Antenatal admissions (not prespecified).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 18 Antenatal admissions (not prespecified).

18.1 Singleton pregnancy

1

426

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.55, 0.90]

18.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19 Phototherapy for neonatal jaundice (not prespecified) Show forest plot

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.87]

Analysis 3.19

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 19 Phototherapy for neonatal jaundice (not prespecified).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 19 Phototherapy for neonatal jaundice (not prespecified).

19.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.87]

19.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20 Antenatal hospital stay (days) (not prespecified) Show forest plot

1

426

Mean Difference (IV, Fixed, 95% CI)

‐0.60 [‐2.39, 1.19]

Analysis 3.20

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 20 Antenatal hospital stay (days) (not prespecified).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 20 Antenatal hospital stay (days) (not prespecified).

20.1 Singleton pregnancy

1

426

Mean Difference (IV, Fixed, 95% CI)

‐0.60 [‐2.39, 1.19]

20.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.3 Singleton plus multiple pregnancies or not stated

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Open in table viewer
Comparison 4. Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

3

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

Analysis 4.1

Comparison 4 Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups), Outcome 1 Any perinatal death after randomisation.

Comparison 4 Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups), Outcome 1 Any perinatal death after randomisation.

1.1 SGA/IUGR

2

572

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.05, 2.09]

1.2 Hypertension/pre‐eclampsia

1

89

Risk Ratio (M‐H, Fixed, 95% CI)

3.57 [0.42, 30.73]

1.3 Diabetes

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.4 Prolonged pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.5 Previous pregnancy loss

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Open in table viewer
Comparison 5. Early ductus venosus Doppler ultrasound versus CTG

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.39, 1.82]

Analysis 5.1

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any perinatal death after randomisation.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any perinatal death after randomisation.

1.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.39, 1.82]

2 Survival following severe neonatal morbidity Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.10 [0.75, 1.61]

Analysis 5.2

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival following severe neonatal morbidity.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival following severe neonatal morbidity.

3 Stillbirth Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.99 [0.37, 10.71]

Analysis 5.3

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.

3.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.99 [0.37, 10.71]

4 Neonatal death Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.60 [0.22, 1.60]

Analysis 5.4

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal death.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal death.

4.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.60 [0.22, 1.60]

5 Any potentially preventable perinatal death* Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.37, 1.86]

Analysis 5.5

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any potentially preventable perinatal death*.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any potentially preventable perinatal death*.

5.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.37, 1.86]

6 Fetal acidosis Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.25 [0.03, 2.20]

Analysis 5.6

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.

6.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.25 [0.03, 2.20]

7 Apgar < 7 at 5 minutes Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.44, 1.72]

Analysis 5.7

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at 5 minutes.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at 5 minutes.

7.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.44, 1.72]

8 Infant requiring intubation/ventilation Show forest plot

1

333

Risk Ratio (M‐H, Random, 95% CI)

0.87 [0.67, 1.13]

Analysis 5.8

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant requiring intubation/ventilation.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant requiring intubation/ventilation.

8.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Random, 95% CI)

0.87 [0.67, 1.13]

9 Intraventricular haemorrhage Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

8.95 [0.49, 164.87]

Analysis 5.9

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 9 Intraventricular haemorrhage.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 9 Intraventricular haemorrhage.

9.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

8.95 [0.49, 164.87]

10 Bronchopulmonary dysplasia Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.55, 1.38]

Analysis 5.10

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 10 Bronchopulmonary dysplasia.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 10 Bronchopulmonary dysplasia.

10.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.55, 1.38]

11 Necrotising enterocolitis Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.03, 3.15]

Analysis 5.11

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 11 Necrotising enterocolitis.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 11 Necrotising enterocolitis.

11.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.03, 3.15]

12 Infant birthweight (grams) Show forest plot

1

333

Mean Difference (IV, Fixed, 95% CI)

38.0 [‐31.53, 107.53]

Analysis 5.12

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant birthweight (grams).

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant birthweight (grams).

12.1 Singleton pregnancy

1

333

Mean Difference (IV, Fixed, 95% CI)

38.0 [‐31.53, 107.53]

13 Long‐term infant neurodevelopmental outcome (impairment at 2 years) Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.60 [0.30, 1.18]

Analysis 5.13

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).

13.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.60 [0.30, 1.18]

14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years) Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.20 [0.02, 1.68]

Analysis 5.14

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).

14.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.20 [0.02, 1.68]

15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified) Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.92, 1.23]

Analysis 5.15

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).

15.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.92, 1.23]

16 Sepsis (proven) (not prespecified) Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.60, 1.45]

Analysis 5.16

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis (proven) (not prespecified).

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis (proven) (not prespecified).

16.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.60, 1.45]

Open in table viewer
Comparison 6. Late ductus venosus Doppler ultrasound versus CTG

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [0.64, 2.55]

Analysis 6.1

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any perinatal death after randomisation.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any perinatal death after randomisation.

1.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [0.64, 2.55]

2 Survival following severe neonatal morbidity Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.66, 1.45]

Analysis 6.2

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival following severe neonatal morbidity.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival following severe neonatal morbidity.

3 Stillbirth Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

2.93 [0.60, 14.31]

Analysis 6.3

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.

3.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

2.93 [0.60, 14.31]

4 Neonatal death Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.47, 2.46]

Analysis 6.4

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal death.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal death.

4.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.47, 2.46]

5 Any potentially preventable perinatal death* Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.22 [0.59, 2.53]

Analysis 6.5

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any potentially preventable perinatal death*.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any potentially preventable perinatal death*.

5.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.22 [0.59, 2.53]

6 Fetal acidosis Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.11 [0.01, 2.00]

Analysis 6.6

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.

6.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.11 [0.01, 2.00]

7 Apgar < 7 at 5 minutes Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [0.69, 2.37]

Analysis 6.7

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at 5 minutes.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at 5 minutes.

7.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [0.69, 2.37]

8 Infant requiring intubation/ventilation Show forest plot

1

336

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.73, 1.20]

Analysis 6.8

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant requiring intubation/ventilation.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant requiring intubation/ventilation.

8.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.73, 1.20]

9 Intraventricular haemorrhage Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

16.60 [0.97, 285.35]

Analysis 6.9

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 9 Intraventricular haemorrhage.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 9 Intraventricular haemorrhage.

9.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

16.60 [0.97, 285.35]

10 Bronchopulmonary dysplasia Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.61, 1.48]

Analysis 6.10

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 10 Bronchopulmonary dysplasia.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 10 Bronchopulmonary dysplasia.

10.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.61, 1.48]

11 Necrotising enterocolitis Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.20, 4.77]

Analysis 6.11

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 11 Necrotising enterocolitis.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 11 Necrotising enterocolitis.

11.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.20, 4.77]

12 Infant birthweight (grams) Show forest plot

1

336

Mean Difference (IV, Fixed, 95% CI)

25.0 [‐40.06, 90.06]

Analysis 6.12

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant birthweight (grams).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant birthweight (grams).

12.1 Singleton pregnancy

1

336

Mean Difference (IV, Fixed, 95% CI)

25.0 [‐40.06, 90.06]

13 Long‐term infant neurodevelopmental outcome (impairment at 2 years) Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.15, 0.79]

Analysis 6.13

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).

13.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.15, 0.79]

14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years) Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.09 [0.00, 1.59]

Analysis 6.14

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).

14.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.09 [0.00, 1.59]

15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified) Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.17 [1.02, 1.34]

Analysis 6.15

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).

15.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.17 [1.02, 1.34]

16 Sepsis (proven) (not prespecified) Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.42, 1.11]

Analysis 6.16

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis (proven) (not prespecified).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis (proven) (not prespecified).

16.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.42, 1.11]

Open in table viewer
Comparison 7. Early ductus venosus Doppler ultrasound versus late

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.66 [0.32, 1.36]

Analysis 7.1

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 1 Any perinatal death after randomisation.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 1 Any perinatal death after randomisation.

1.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.66 [0.32, 1.36]

2 Survival following severe neonatal morbidity Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.13 [0.77, 1.65]

Analysis 7.2

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 2 Survival following severe neonatal morbidity.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 2 Survival following severe neonatal morbidity.

3 Stillbirth Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.20, 2.36]

Analysis 7.3

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 3 Stillbirth.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 3 Stillbirth.

3.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.20, 2.36]

4 Neonatal death Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.56 [0.21, 1.47]

Analysis 7.4

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 4 Neonatal death.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 4 Neonatal death.

4.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.56 [0.21, 1.47]

5 Any potentially preventable perinatal death* Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.31, 1.47]

Analysis 7.5

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 5 Any potentially preventable perinatal death*.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 5 Any potentially preventable perinatal death*.

5.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.31, 1.47]

6 Fetal acidosis Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

3.05 [0.13, 74.43]

Analysis 7.6

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 6 Fetal acidosis.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 6 Fetal acidosis.

6.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

3.05 [0.13, 74.43]

7 Apgar < 7 at 5 minutes Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.36, 1.29]

Analysis 7.7

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 7 Apgar < 7 at 5 minutes.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 7 Apgar < 7 at 5 minutes.

7.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.36, 1.29]

8 Infant requiring intubation/ventilation Show forest plot

1

337

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.71, 1.21]

Analysis 7.8

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 8 Infant requiring intubation/ventilation.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 8 Infant requiring intubation/ventilation.

8.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.71, 1.21]

9 Intraventricular haemorrhage Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.51 [0.16, 1.66]

Analysis 7.9

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 9 Intraventricular haemorrhage.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 9 Intraventricular haemorrhage.

9.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.51 [0.16, 1.66]

10 Bronchopulmonary dysplasia Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.58, 1.46]

Analysis 7.10

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 10 Bronchopulmonary dysplasia.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 10 Bronchopulmonary dysplasia.

10.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.58, 1.46]

11 Necrotising enterocolitis Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.04, 3.23]

Analysis 7.11

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 11 Necrotising enterocolitis.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 11 Necrotising enterocolitis.

11.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.04, 3.23]

12 Infant birthweight (grams) Show forest plot

1

337

Mean Difference (IV, Fixed, 95% CI)

13.0 [‐59.31, 85.31]

Analysis 7.12

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 12 Infant birthweight (grams).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 12 Infant birthweight (grams).

12.1 Singleton pregnancy

1

337

Mean Difference (IV, Fixed, 95% CI)

13.0 [‐59.31, 85.31]

13 Long‐term infant neurodevelopmental outcome (impairment at 2 years) Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.75 [0.70, 4.32]

Analysis 7.13

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).

13.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.75 [0.70, 4.32]

14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years) Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

3.05 [0.13, 74.43]

Analysis 7.14

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).

14.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

3.05 [0.13, 74.43]

15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified) Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.80, 1.03]

Analysis 7.15

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).

15.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.80, 1.03]

16 Sepsis (proven) (not prespecified) Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.37 [0.84, 2.25]

Analysis 7.16

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 16 Sepsis (proven) (not prespecified).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 16 Sepsis (proven) (not prespecified).

16.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.37 [0.84, 2.25]

Study flow diagram.
Figures and Tables -
Figure 1

Study flow diagram.

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
Figures and Tables -
Figure 2

Methodological quality summary: review authors' judgements about each methodological quality item for each included study.

Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.1 Any perinatal death after randomisation.
Figures and Tables -
Figure 3

Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.1 Any perinatal death after randomisation.

Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.8 Cesarean section (elective and emergency).
Figures and Tables -
Figure 4

Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.8 Cesarean section (elective and emergency).

Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.9 Cesarean section ‐ elective.
Figures and Tables -
Figure 5

Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.9 Cesarean section ‐ elective.

Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.10 Cesarean section ‐ emergency.
Figures and Tables -
Figure 6

Funnel plot of comparison: 1 Doppler ultrasound versus no Doppler ultrasound, outcome: 1.10 Cesarean section ‐ emergency.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 1 Any perinatal death after randomisation.
Figures and Tables -
Analysis 1.1

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 1 Any perinatal death after randomisation.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 2 Serious neonatal morbidity.
Figures and Tables -
Analysis 1.2

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 2 Serious neonatal morbidity.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 3 Stillbirth.
Figures and Tables -
Analysis 1.3

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 3 Stillbirth.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 4 Neonatal death.
Figures and Tables -
Analysis 1.4

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 4 Neonatal death.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 5 Any potentially preventable perinatal death*.
Figures and Tables -
Analysis 1.5

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 5 Any potentially preventable perinatal death*.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 6 Apgar < 7 at 5 minutes.
Figures and Tables -
Analysis 1.6

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 6 Apgar < 7 at 5 minutes.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 7 Caesarean section (elective and emergency).
Figures and Tables -
Analysis 1.7

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 7 Caesarean section (elective and emergency).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 8 Caesarean section ‐ elective.
Figures and Tables -
Analysis 1.8

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 8 Caesarean section ‐ elective.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 9 Caesarean section ‐ emergency.
Figures and Tables -
Analysis 1.9

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 9 Caesarean section ‐ emergency.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 10 Spontaneous vaginal birth.
Figures and Tables -
Analysis 1.10

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 10 Spontaneous vaginal birth.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 11 Operative vaginal birth.
Figures and Tables -
Analysis 1.11

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 11 Operative vaginal birth.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 12 Induction of labour.
Figures and Tables -
Analysis 1.12

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 12 Induction of labour.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 13 Infant requiring intubation/ventilation.
Figures and Tables -
Analysis 1.13

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 13 Infant requiring intubation/ventilation.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 14 Neonatal fitting/seizures.
Figures and Tables -
Analysis 1.14

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 14 Neonatal fitting/seizures.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 15 Preterm labour.
Figures and Tables -
Analysis 1.15

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 15 Preterm labour.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 16 Gestational age at birth (weeks).
Figures and Tables -
Analysis 1.16

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 16 Gestational age at birth (weeks).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 17 Infant respiratory distress syndrome (RDS).
Figures and Tables -
Analysis 1.17

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 17 Infant respiratory distress syndrome (RDS).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 18 Neonatal admission to SCBU and/or NICU.
Figures and Tables -
Analysis 1.18

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 18 Neonatal admission to SCBU and/or NICU.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 19 Hypoxic ischaemic encephalopathy.
Figures and Tables -
Analysis 1.19

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 19 Hypoxic ischaemic encephalopathy.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 20 Intraventricular haemorrhage.
Figures and Tables -
Analysis 1.20

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 20 Intraventricular haemorrhage.

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 21 Birthweight (grams).
Figures and Tables -
Analysis 1.21

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 21 Birthweight (grams).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 22 Length of infant hospital stay (days).
Figures and Tables -
Analysis 1.22

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 22 Length of infant hospital stay (days).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 23 Birth < 34 weeks (not prespecified).
Figures and Tables -
Analysis 1.23

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 23 Birth < 34 weeks (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 24 Antenatal admissions (not prespecified).
Figures and Tables -
Analysis 1.24

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 24 Antenatal admissions (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 25 Phototherapy for neonatal jaundice (not prespecified).
Figures and Tables -
Analysis 1.25

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 25 Phototherapy for neonatal jaundice (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 26 Abnormal neurological development at 9 months (not prespecified).
Figures and Tables -
Analysis 1.26

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 26 Abnormal neurological development at 9 months (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 27 Hospitalisation for IUGR neonatal (not prespecified).
Figures and Tables -
Analysis 1.27

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 27 Hospitalisation for IUGR neonatal (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 28 Fetal distress in labour (not prespecified).
Figures and Tables -
Analysis 1.28

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 28 Fetal distress in labour (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 29 Birthweight < 5 percentile (not prespecified).
Figures and Tables -
Analysis 1.29

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 29 Birthweight < 5 percentile (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 30 Periventricular leucomalacia (not prespecified).
Figures and Tables -
Analysis 1.30

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 30 Periventricular leucomalacia (not prespecified).

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 31 Antenatal hospital stay (days) (not prespecified).
Figures and Tables -
Analysis 1.31

Comparison 1 Umbilical artery Doppler ultrasound versus no Doppler ultrasound, Outcome 31 Antenatal hospital stay (days) (not prespecified).

Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups), Outcome 1 Any perinatal death after randomisation.
Figures and Tables -
Analysis 2.1

Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups), Outcome 1 Any perinatal death after randomisation.

Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups), Outcome 2 Serious neonatal morbidity.
Figures and Tables -
Analysis 2.2

Comparison 2 Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups), Outcome 2 Serious neonatal morbidity.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 1 Any perinatal death after randomisation.
Figures and Tables -
Analysis 3.1

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 1 Any perinatal death after randomisation.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 2 Stillbirth.
Figures and Tables -
Analysis 3.2

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 2 Stillbirth.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 3 Neonatal death.
Figures and Tables -
Analysis 3.3

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 3 Neonatal death.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 4 Any potentially preventable perinatal death*.
Figures and Tables -
Analysis 3.4

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 4 Any potentially preventable perinatal death*.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 5 Apgar < 7 at 5 minutes.
Figures and Tables -
Analysis 3.5

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 5 Apgar < 7 at 5 minutes.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 6 Caesarean section (elective and emergency).
Figures and Tables -
Analysis 3.6

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 6 Caesarean section (elective and emergency).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 7 Caesarean section ‐ elective.
Figures and Tables -
Analysis 3.7

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 7 Caesarean section ‐ elective.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 8 Caesarean section ‐ emergency.
Figures and Tables -
Analysis 3.8

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 8 Caesarean section ‐ emergency.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 9 Spontaneous vaginal birth.
Figures and Tables -
Analysis 3.9

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 9 Spontaneous vaginal birth.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 10 Operative vaginal birth.
Figures and Tables -
Analysis 3.10

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 10 Operative vaginal birth.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 11 Induction of labour.
Figures and Tables -
Analysis 3.11

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 11 Induction of labour.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 12 Infant requiring intubation/ventilation.
Figures and Tables -
Analysis 3.12

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 12 Infant requiring intubation/ventilation.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 13 Neonatal fitting/seizures.
Figures and Tables -
Analysis 3.13

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 13 Neonatal fitting/seizures.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 14 Gestational age at birth.
Figures and Tables -
Analysis 3.14

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 14 Gestational age at birth.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 15 Neonatal admission to SCBU and/or NICU.
Figures and Tables -
Analysis 3.15

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 15 Neonatal admission to SCBU and/or NICU.

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 16 Infant birthweight (grams).
Figures and Tables -
Analysis 3.16

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 16 Infant birthweight (grams).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 17 Length of infant hospital stay (days).
Figures and Tables -
Analysis 3.17

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 17 Length of infant hospital stay (days).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 18 Antenatal admissions (not prespecified).
Figures and Tables -
Analysis 3.18

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 18 Antenatal admissions (not prespecified).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 19 Phototherapy for neonatal jaundice (not prespecified).
Figures and Tables -
Analysis 3.19

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 19 Phototherapy for neonatal jaundice (not prespecified).

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 20 Antenatal hospital stay (days) (not prespecified).
Figures and Tables -
Analysis 3.20

Comparison 3 Umbilical artery Doppler ultrasound alone versus CTG alone, Outcome 20 Antenatal hospital stay (days) (not prespecified).

Comparison 4 Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups), Outcome 1 Any perinatal death after randomisation.
Figures and Tables -
Analysis 4.1

Comparison 4 Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups), Outcome 1 Any perinatal death after randomisation.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any perinatal death after randomisation.
Figures and Tables -
Analysis 5.1

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any perinatal death after randomisation.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival following severe neonatal morbidity.
Figures and Tables -
Analysis 5.2

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival following severe neonatal morbidity.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.
Figures and Tables -
Analysis 5.3

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal death.
Figures and Tables -
Analysis 5.4

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal death.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any potentially preventable perinatal death*.
Figures and Tables -
Analysis 5.5

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any potentially preventable perinatal death*.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.
Figures and Tables -
Analysis 5.6

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at 5 minutes.
Figures and Tables -
Analysis 5.7

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at 5 minutes.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant requiring intubation/ventilation.
Figures and Tables -
Analysis 5.8

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant requiring intubation/ventilation.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 9 Intraventricular haemorrhage.
Figures and Tables -
Analysis 5.9

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 9 Intraventricular haemorrhage.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 10 Bronchopulmonary dysplasia.
Figures and Tables -
Analysis 5.10

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 10 Bronchopulmonary dysplasia.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 11 Necrotising enterocolitis.
Figures and Tables -
Analysis 5.11

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 11 Necrotising enterocolitis.

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant birthweight (grams).
Figures and Tables -
Analysis 5.12

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant birthweight (grams).

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).
Figures and Tables -
Analysis 5.13

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).
Figures and Tables -
Analysis 5.14

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).
Figures and Tables -
Analysis 5.15

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis (proven) (not prespecified).
Figures and Tables -
Analysis 5.16

Comparison 5 Early ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis (proven) (not prespecified).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any perinatal death after randomisation.
Figures and Tables -
Analysis 6.1

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 1 Any perinatal death after randomisation.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival following severe neonatal morbidity.
Figures and Tables -
Analysis 6.2

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 2 Survival following severe neonatal morbidity.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.
Figures and Tables -
Analysis 6.3

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 3 Stillbirth.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal death.
Figures and Tables -
Analysis 6.4

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 4 Neonatal death.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any potentially preventable perinatal death*.
Figures and Tables -
Analysis 6.5

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 5 Any potentially preventable perinatal death*.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.
Figures and Tables -
Analysis 6.6

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 6 Fetal acidosis.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at 5 minutes.
Figures and Tables -
Analysis 6.7

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 7 Apgar < 7 at 5 minutes.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant requiring intubation/ventilation.
Figures and Tables -
Analysis 6.8

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 8 Infant requiring intubation/ventilation.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 9 Intraventricular haemorrhage.
Figures and Tables -
Analysis 6.9

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 9 Intraventricular haemorrhage.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 10 Bronchopulmonary dysplasia.
Figures and Tables -
Analysis 6.10

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 10 Bronchopulmonary dysplasia.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 11 Necrotising enterocolitis.
Figures and Tables -
Analysis 6.11

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 11 Necrotising enterocolitis.

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant birthweight (grams).
Figures and Tables -
Analysis 6.12

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 12 Infant birthweight (grams).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).
Figures and Tables -
Analysis 6.13

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).
Figures and Tables -
Analysis 6.14

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).
Figures and Tables -
Analysis 6.15

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis (proven) (not prespecified).
Figures and Tables -
Analysis 6.16

Comparison 6 Late ductus venosus Doppler ultrasound versus CTG, Outcome 16 Sepsis (proven) (not prespecified).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 1 Any perinatal death after randomisation.
Figures and Tables -
Analysis 7.1

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 1 Any perinatal death after randomisation.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 2 Survival following severe neonatal morbidity.
Figures and Tables -
Analysis 7.2

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 2 Survival following severe neonatal morbidity.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 3 Stillbirth.
Figures and Tables -
Analysis 7.3

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 3 Stillbirth.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 4 Neonatal death.
Figures and Tables -
Analysis 7.4

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 4 Neonatal death.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 5 Any potentially preventable perinatal death*.
Figures and Tables -
Analysis 7.5

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 5 Any potentially preventable perinatal death*.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 6 Fetal acidosis.
Figures and Tables -
Analysis 7.6

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 6 Fetal acidosis.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 7 Apgar < 7 at 5 minutes.
Figures and Tables -
Analysis 7.7

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 7 Apgar < 7 at 5 minutes.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 8 Infant requiring intubation/ventilation.
Figures and Tables -
Analysis 7.8

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 8 Infant requiring intubation/ventilation.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 9 Intraventricular haemorrhage.
Figures and Tables -
Analysis 7.9

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 9 Intraventricular haemorrhage.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 10 Bronchopulmonary dysplasia.
Figures and Tables -
Analysis 7.10

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 10 Bronchopulmonary dysplasia.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 11 Necrotising enterocolitis.
Figures and Tables -
Analysis 7.11

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 11 Necrotising enterocolitis.

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 12 Infant birthweight (grams).
Figures and Tables -
Analysis 7.12

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 12 Infant birthweight (grams).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).
Figures and Tables -
Analysis 7.13

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 13 Long‐term infant neurodevelopmental outcome (impairment at 2 years).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).
Figures and Tables -
Analysis 7.14

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).
Figures and Tables -
Analysis 7.15

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified).

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 16 Sepsis (proven) (not prespecified).
Figures and Tables -
Analysis 7.16

Comparison 7 Early ductus venosus Doppler ultrasound versus late, Outcome 16 Sepsis (proven) (not prespecified).

Summary of findings for the main comparison. Umbilical artery Doppler ultrasound compared to no Doppler ultrasound in high‐risk pregnancies

Umbilical artery Doppler ultrasound compared to no Doppler ultrasound in high‐risk pregnancies

Patient or population: pregnant women at increased risk of fetal complications
Setting: antenatal clinics or inpatient wards in hospitals in Australia (3) UK (6) US (2) Sweden (1) South Africa (2) Ireland (1) The Netherlands (1) France (1) Canada (1)
Intervention: umbilical artery Doppler ultrasound
Comparison: no Doppler ultrasound

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

№ of participants
(studies)

Quality of the evidence
(GRADE)

Comments

Risk with no Doppler ultrasound

Risk with umbilical artery Doppler ultrasound

Any perinatal death after randomisation

Study population

RR 0.71
(0.52 to 0.98)

10225
(16 RCTs)

⊕⊕⊕⊝
MODERATE 1 2

17 per 1000

12 per 1000
(9 to 17)

Serious neonatal morbidity

Study population

1098
(3 RCTs)

⊕⊝⊝⊝
VERY LOW 1 3 4

We did not pool the data for this outcome due to high heterogeneity (the direction of effect in the 2 studies contributing data were not consistent).

Stillbirth

Study population

RR 0.65
(0.41 to 1.04)

9560
(15 RCTs)

⊕⊕⊝⊝
LOW 1 2 5

9 per 1000

6 per 1000
(4 to 9)

Apgar < 7 at 5 minutes

Study population

RR 0.92
(0.69 to 1.24)

6321
(7 RCTs)

⊕⊕⊝⊝
LOW 1 5

29 per 1000

26 per 1000
(20 to 36)

Caesarean section (elective and emergency)

Study population

RR 0.90
(0.84 to 0.97)

7918
(14 RCTs)

⊕⊕⊕⊝
MODERATE 1 2

263 per 1000

237 per 1000
(221 to 255)

Induction of labour

Study population

RR 0.89
(0.80 to 0.99)

5633
(10 RCTs)

⊕⊕⊕⊝
MODERATE 1 2

334 per 1000

298 per 1000
(268 to 331)

Long‐term infant neurodevelopmental outcome (impairment at 2 years)

Study population

(0 studies)

There has been no comparative long‐term follow‐up of babies exposed to Doppler ultrasound in pregnancy in women at increased risk of complications.

see comment

see comment

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

CI: Confidence interval; RR: Risk ratio; OR: Odds ratio;

GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 All studies assessed as having design limitations due to lack of information.

2 Although there was some evidence of funnel plot asymmetry suggesting small‐study effect (with studies with smaller sample sizes appearing to have a more pronounced effect), we did not downgrade for publication bias because, for our selected outcomes, individual studies did not reach statistical significance and there was low heterogeneity across all studies for this outcome.

3 High heterogeneity (I² statistic 76%) with direction of effect different in the 2 studies contributing data.

4 95% CI crossing the line of no effect. Low event rate.

5 Wide 95% CI crossing the line of no effect.

Figures and Tables -
Summary of findings for the main comparison. Umbilical artery Doppler ultrasound compared to no Doppler ultrasound in high‐risk pregnancies
Comparison 1. Umbilical artery Doppler ultrasound versus no Doppler ultrasound

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

16

10225

Risk Ratio (M‐H, Fixed, 95% CI)

0.71 [0.52, 0.98]

1.1 Singleton pregnancy

9

4661

Risk Ratio (M‐H, Fixed, 95% CI)

0.59 [0.35, 1.01]

1.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.32, 2.41]

1.3 Singleton plus multiple pregnancies, or not stated

6

4512

Risk Ratio (M‐H, Fixed, 95% CI)

0.78 [0.51, 1.19]

2 Serious neonatal morbidity Show forest plot

3

Risk Ratio (M‐H, Random, 95% CI)

Subtotals only

2.1 Singleton pregnancy

1

500

Risk Ratio (M‐H, Random, 95% CI)

0.13 [0.02, 0.99]

2.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.3 Singleton plus multiple pregnancies, or not stated

2

598

Risk Ratio (M‐H, Random, 95% CI)

2.95 [0.31, 28.14]

3 Stillbirth Show forest plot

15

9560

Risk Ratio (M‐H, Fixed, 95% CI)

0.65 [0.41, 1.04]

3.1 Singleton pregnancy

8

3996

Risk Ratio (M‐H, Fixed, 95% CI)

0.61 [0.31, 1.19]

3.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.67 [0.11, 4.00]

3.3 Singleton plus multiple pregnancy, or not stated

6

4512

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.35, 1.39]

4 Neonatal death Show forest plot

13

8167

Risk Ratio (M‐H, Fixed, 95% CI)

0.81 [0.53, 1.24]

4.1 Singleton pregnancy

7

2656

Risk Ratio (M‐H, Fixed, 95% CI)

0.69 [0.31, 1.53]

4.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.29, 3.46]

4.3 Singleton plus multiple pregnancies, or not stated

5

4459

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.48, 1.45]

5 Any potentially preventable perinatal death* Show forest plot

16

10225

Risk Ratio (M‐H, Fixed, 95% CI)

0.67 [0.46, 0.98]

5.1 Singleton pregnancy

9

4661

Risk Ratio (M‐H, Fixed, 95% CI)

0.58 [0.30, 1.13]

5.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.32, 2.41]

5.3 Singleton plus multiple pregnancies or not stated

6

4512

Risk Ratio (M‐H, Fixed, 95% CI)

0.69 [0.41, 1.15]

6 Apgar < 7 at 5 minutes Show forest plot

7

6321

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.69, 1.24]

6.1 Singleton pregnancy

4

2555

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.45, 1.09]

6.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.3 Singleton plus multiple pregnancies or not stated

3

3766

Risk Ratio (M‐H, Fixed, 95% CI)

1.16 [0.77, 1.73]

7 Caesarean section (elective and emergency) Show forest plot

14

7918

Risk Ratio (M‐H, Fixed, 95% CI)

0.90 [0.84, 0.97]

7.1 Singleton pregnancy

7

2929

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.75, 0.95]

7.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.77, 1.19]

7.3 Singleton plus multiple pregnancies or not stated

6

4463

Risk Ratio (M‐H, Fixed, 95% CI)

0.94 [0.84, 1.05]

8 Caesarean section ‐ elective Show forest plot

11

6627

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.93, 1.22]

8.1 Singleton pregnancy

6

1934

Risk Ratio (M‐H, Fixed, 95% CI)

1.11 [0.90, 1.38]

8.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.77, 1.47]

8.3 Singleton plus multiple pregnancies or not stated

4

4167

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.84, 1.26]

9 Caesarean section ‐ emergency Show forest plot

10

6175

Risk Ratio (M‐H, Random, 95% CI)

0.81 [0.67, 0.98]

9.1 Singleton pregnancy

5

1482

Risk Ratio (M‐H, Random, 95% CI)

0.58 [0.43, 0.78]

9.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Random, 95% CI)

0.84 [0.57, 1.23]

9.3 Singleton plus multiple pregnancies or not stated

4

4167

Risk Ratio (M‐H, Random, 95% CI)

0.96 [0.77, 1.20]

10 Spontaneous vaginal birth Show forest plot

5

2504

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.98, 1.10]

10.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.96, 1.18]

10.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.90, 1.19]

10.3 Singleton plus multiple pregnancies or not stated

2

1402

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.95, 1.12]

11 Operative vaginal birth Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.80, 1.14]

11.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.97 [0.78, 1.22]

11.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

11.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.68, 1.25]

12 Induction of labour Show forest plot

10

5633

Risk Ratio (M‐H, Random, 95% CI)

0.89 [0.80, 0.99]

12.1 Singleton pregnancy

5

1784

Risk Ratio (M‐H, Random, 95% CI)

0.79 [0.64, 0.97]

12.2 Multiple pregnancy

1

526

Risk Ratio (M‐H, Random, 95% CI)

1.10 [0.80, 1.50]

12.3 Singleton plus multiple pregnancies or not stated

4

3323

Risk Ratio (M‐H, Random, 95% CI)

0.95 [0.86, 1.04]

13 Infant requiring intubation/ventilation Show forest plot

6

3136

Risk Ratio (M‐H, Random, 95% CI)

1.42 [0.87, 2.30]

13.1 Singleton pregnancy

4

1539

Risk Ratio (M‐H, Random, 95% CI)

2.89 [1.40, 5.96]

13.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Random, 95% CI)

0.86 [0.59, 1.25]

13.3 Singleton plus multiple pregnancies or not stated

1

545

Risk Ratio (M‐H, Random, 95% CI)

1.25 [0.79, 1.98]

14 Neonatal fitting/seizures Show forest plot

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.01, 8.49]

14.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.01, 8.49]

14.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

14.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15 Preterm labour Show forest plot

2

626

Risk Ratio (M‐H, Fixed, 95% CI)

1.12 [0.72, 1.75]

15.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.51, 2.07]

15.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15.3 Singleton plus multiple pregnancy or not stated

1

476

Risk Ratio (M‐H, Fixed, 95% CI)

1.18 [0.66, 2.11]

16 Gestational age at birth (weeks) Show forest plot

8

4066

Mean Difference (IV, Random, 95% CI)

0.21 [‐0.02, 0.43]

16.1 Singleton pregnancy

3

1043

Mean Difference (IV, Random, 95% CI)

0.54 [‐0.00, 1.09]

16.2 Multiple pregnancy

1

1052

Mean Difference (IV, Random, 95% CI)

0.10 [‐0.24, 0.44]

16.3 Singleton plus multiple pregnancies or not stated

4

1971

Mean Difference (IV, Random, 95% CI)

0.06 [‐0.19, 0.31]

17 Infant respiratory distress syndrome (RDS) Show forest plot

1

107

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.07, 16.48]

17.1 Singleton pregnancy

1

107

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.07, 16.48]

17.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18 Neonatal admission to SCBU and/or NICU Show forest plot

12

9334

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.89, 1.03]

18.1 Singleton pregnancy

8

4511

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.80, 1.06]

18.2 Multiple pregnancy

1

1052

Risk Ratio (M‐H, Fixed, 95% CI)

0.96 [0.88, 1.05]

18.3 Singleton plus multiple pregnancies or not stated

3

3771

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.85, 1.14]

19 Hypoxic ischaemic encephalopathy Show forest plot

2

1045

Risk Ratio (M‐H, Random, 95% CI)

0.65 [0.01, 33.07]

19.1 Singleton pregnancy

1

500

Risk Ratio (M‐H, Random, 95% CI)

0.09 [0.01, 1.64]

19.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

19.3 Singleton plus multiple pregnancies or not stated

1

545

Risk Ratio (M‐H, Random, 95% CI)

4.91 [0.24, 101.79]

20 Intraventricular haemorrhage Show forest plot

4

2008

Risk Ratio (M‐H, Fixed, 95% CI)

1.42 [0.47, 4.30]

20.1 Singleton pregnancy

3

1463

Risk Ratio (M‐H, Fixed, 95% CI)

1.26 [0.38, 4.16]

20.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.3 Singleton plus multiple pregnancies or not stated

1

545

Risk Ratio (M‐H, Fixed, 95% CI)

2.95 [0.12, 71.99]

21 Birthweight (grams) Show forest plot

7

3887

Mean Difference (IV, Fixed, 95% CI)

31.33 [‐8.70, 71.37]

21.1 Singleton pregnancy

3

1916

Mean Difference (IV, Fixed, 95% CI)

49.34 [‐0.62, 99.31]

21.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

21.3 Singleton plus multiple pregnancies or not stated

4

1971

Mean Difference (IV, Fixed, 95% CI)

‐0.95 [‐67.84, 65.95]

22 Length of infant hospital stay (days) Show forest plot

3

1076

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.28 [‐0.40, ‐0.16]

22.1 Singleton pregnancy

3

1076

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.28 [‐0.40, ‐0.16]

22.2 Multiple pregnancy

0

0

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

22.3 Singleton plus multiple pregnancies or not stated

0

0

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

23 Birth < 34 weeks (not prespecified) Show forest plot

2

976

Risk Ratio (M‐H, Random, 95% CI)

2.04 [0.62, 6.69]

23.1 Singleton pregnancy

1

500

Risk Ratio (M‐H, Random, 95% CI)

1.17 [0.40, 3.42]

23.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

23.3 Singleton plus multiple pregnancies or not stated

1

476

Risk Ratio (M‐H, Random, 95% CI)

3.90 [1.11, 13.65]

24 Antenatal admissions (not prespecified) Show forest plot

2

893

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.60, 0.88]

24.1 Singleton pregnancy

2

893

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.60, 0.88]

24.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

24.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25 Phototherapy for neonatal jaundice (not prespecified) Show forest plot

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.87]

25.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.87]

25.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

25.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26 Abnormal neurological development at 9 months (not prespecified) Show forest plot

1

137

Risk Ratio (M‐H, Fixed, 95% CI)

0.61 [0.26, 1.45]

26.1 Singleton pregnancy

1

137

Risk Ratio (M‐H, Fixed, 95% CI)

0.61 [0.26, 1.45]

26.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

26.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27 Hospitalisation for IUGR neonatal (not prespecified) Show forest plot

1

142

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.75, 1.41]

27.1 Singleton pregnancy

1

142

Risk Ratio (M‐H, Fixed, 95% CI)

1.03 [0.75, 1.41]

27.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

27.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28 Fetal distress in labour (not prespecified) Show forest plot

1

289

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.10, 1.22]

28.1 Singleton pregnancy

1

289

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.10, 1.22]

28.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

28.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29 Birthweight < 5 percentile (not prespecified) Show forest plot

1

289

Risk Ratio (M‐H, Fixed, 95% CI)

1.16 [0.51, 2.64]

29.1 Singleton pregnancy

1

289

Risk Ratio (M‐H, Fixed, 95% CI)

1.16 [0.51, 2.64]

29.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

29.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30 Periventricular leucomalacia (not prespecified) Show forest plot

1

545

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.01, 8.00]

30.1 Singleton pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

30.3 Singleton plus multiple pregnancies or not stated

1

545

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.01, 8.00]

31 Antenatal hospital stay (days) (not prespecified) Show forest plot

1

426

Mean Difference (IV, Fixed, 95% CI)

‐0.60 [‐2.39, 1.19]

31.1 Singleton pregnancy

1

426

Mean Difference (IV, Fixed, 95% CI)

‐0.60 [‐2.39, 1.19]

31.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

31.3 Singleton plus multiple pregnancies or not stated

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 1. Umbilical artery Doppler ultrasound versus no Doppler ultrasound
Comparison 2. Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

6

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

1.1 SGA/IUGR

5

1292

Risk Ratio (M‐H, Fixed, 95% CI)

0.72 [0.38, 1.35]

1.2 Hypertension/pre‐eclampsia

1

89

Risk Ratio (M‐H, Fixed, 95% CI)

3.57 [0.42, 30.73]

1.3 Diabetes

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.4 Prolonged pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.5 Previous pregnancy loss

1

53

Risk Ratio (M‐H, Fixed, 95% CI)

0.26 [0.03, 2.17]

2 Serious neonatal morbidity Show forest plot

1

53

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.1 SGA/IUGR

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.2 Hypertension/pre‐eclampsia

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.3 Diabetes

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.4 Prolonged pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

2.5 Previous pregnancy loss

1

53

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 2. Umbilical artery Doppler ultrasound versus no Doppler ultrasound (all subgroups)
Comparison 3. Umbilical artery Doppler ultrasound alone versus CTG alone

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.45 [0.17, 1.15]

1.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.07, 1.68]

1.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.52 [0.16, 1.73]

2 Stillbirth Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.48 [0.14, 1.71]

2.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.28 [0.05, 1.70]

2.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

2.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

1.05 [0.15, 7.41]

3 Neonatal death Show forest plot

3

1473

Risk Ratio (M‐H, Fixed, 95% CI)

0.52 [0.16, 1.72]

3.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.02 [0.15, 7.10]

3.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

3.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.07, 1.72]

4 Any potentially preventable perinatal death* Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.38 [0.12, 1.18]

4.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.41 [0.08, 2.11]

4.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

4.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.07, 1.72]

5 Apgar < 7 at 5 minutes Show forest plot

3

2663

Risk Ratio (M‐H, Fixed, 95% CI)

0.86 [0.54, 1.37]

5.1 Singleton pregnancy

2

1766

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.49, 1.43]

5.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

5.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.36, 2.39]

6 Caesarean section (elective and emergency) Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.79, 1.01]

6.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.89 [0.77, 1.02]

6.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

6.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.73, 1.14]

7 Caesarean section ‐ elective Show forest plot

3

1473

Risk Ratio (M‐H, Fixed, 95% CI)

1.53 [1.12, 2.09]

7.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.69 [1.07, 2.67]

7.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

7.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

1.40 [0.91, 2.15]

8 Caesarean section ‐ emergency Show forest plot

3

1473

Risk Ratio (M‐H, Fixed, 95% CI)

0.66 [0.52, 0.84]

8.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

0.55 [0.36, 0.83]

8.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

8.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.73 [0.55, 0.98]

9 Spontaneous vaginal birth Show forest plot

2

1323

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.97, 1.15]

9.1 Singleton pregnancy

1

426

Risk Ratio (M‐H, Fixed, 95% CI)

1.04 [0.91, 1.19]

9.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

9.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

1.06 [0.95, 1.19]

10 Operative vaginal birth Show forest plot

3

2663

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.81, 1.17]

10.1 Singleton pregnancy

2

1766

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.80, 1.27]

10.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

10.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.68, 1.25]

11 Induction of labour Show forest plot

2

576

Risk Ratio (M‐H, Random, 95% CI)

0.67 [0.32, 1.40]

11.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Random, 95% CI)

0.67 [0.32, 1.40]

11.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

11.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Random, 95% CI)

0.0 [0.0, 0.0]

12 Infant requiring intubation/ventilation Show forest plot

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.54 [0.26, 9.08]

12.1 Singleton pregnancy

2

576

Risk Ratio (M‐H, Fixed, 95% CI)

1.54 [0.26, 9.08]

12.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

12.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13 Neonatal fitting/seizures Show forest plot

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.01, 8.49]

13.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.35 [0.01, 8.49]

13.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

13.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

14 Gestational age at birth Show forest plot

3

1473

Mean Difference (IV, Fixed, 95% CI)

0.23 [‐0.00, 0.47]

14.1 Singleton pregnancy

2

576

Mean Difference (IV, Fixed, 95% CI)

0.26 [‐0.06, 0.59]

14.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

14.3 Singleton plus multiple pregnancies or not stated

1

897

Mean Difference (IV, Fixed, 95% CI)

0.20 [‐0.15, 0.55]

15 Neonatal admission to SCBU and/or NICU Show forest plot

4

2813

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.73, 1.03]

15.1 Singleton pregnancy

3

1916

Risk Ratio (M‐H, Fixed, 95% CI)

0.80 [0.64, 0.99]

15.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

15.3 Singleton plus multiple pregnancies or not stated

1

897

Risk Ratio (M‐H, Fixed, 95% CI)

1.00 [0.73, 1.37]

16 Infant birthweight (grams) Show forest plot

4

2813

Mean Difference (IV, Fixed, 95% CI)

38.41 [‐6.14, 82.97]

16.1 Singleton pregnancy

3

1916

Mean Difference (IV, Fixed, 95% CI)

49.34 [‐0.62, 99.31]

16.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

16.3 Singleton plus multiple pregnancies or not stated

1

897

Mean Difference (IV, Fixed, 95% CI)

‐4.0 [‐102.42, 94.42]

17 Length of infant hospital stay (days) Show forest plot

2

576

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.25 [‐0.41, ‐0.08]

17.1 Singleton pregnancy

2

576

Std. Mean Difference (IV, Fixed, 95% CI)

‐0.25 [‐0.41, ‐0.08]

17.2 Multiple pregnancy

0

0

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

17.3 Singleton plus multiple pregnancies or not stated

0

0

Std. Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

18 Antenatal admissions (not prespecified) Show forest plot

1

426

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.55, 0.90]

18.1 Singleton pregnancy

1

426

Risk Ratio (M‐H, Fixed, 95% CI)

0.70 [0.55, 0.90]

18.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

18.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19 Phototherapy for neonatal jaundice (not prespecified) Show forest plot

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.87]

19.1 Singleton pregnancy

1

150

Risk Ratio (M‐H, Fixed, 95% CI)

0.15 [0.01, 2.87]

19.2 Multiple pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

19.3 Singleton plus multiple pregnancies or not stated

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

20 Antenatal hospital stay (days) (not prespecified) Show forest plot

1

426

Mean Difference (IV, Fixed, 95% CI)

‐0.60 [‐2.39, 1.19]

20.1 Singleton pregnancy

1

426

Mean Difference (IV, Fixed, 95% CI)

‐0.60 [‐2.39, 1.19]

20.2 Multiple pregnancy

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

20.3 Singleton plus multiple pregnancies or not stated

0

0

Mean Difference (IV, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 3. Umbilical artery Doppler ultrasound alone versus CTG alone
Comparison 4. Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups)

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

3

Risk Ratio (M‐H, Fixed, 95% CI)

Subtotals only

1.1 SGA/IUGR

2

572

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.05, 2.09]

1.2 Hypertension/pre‐eclampsia

1

89

Risk Ratio (M‐H, Fixed, 95% CI)

3.57 [0.42, 30.73]

1.3 Diabetes

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.4 Prolonged pregnancy

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

1.5 Previous pregnancy loss

0

0

Risk Ratio (M‐H, Fixed, 95% CI)

0.0 [0.0, 0.0]

Figures and Tables -
Comparison 4. Umbilical artery Doppler ultrasound alone versus CTG alone (all subgroups)
Comparison 5. Early ductus venosus Doppler ultrasound versus CTG

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.39, 1.82]

1.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.84 [0.39, 1.82]

2 Survival following severe neonatal morbidity Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.10 [0.75, 1.61]

3 Stillbirth Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.99 [0.37, 10.71]

3.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.99 [0.37, 10.71]

4 Neonatal death Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.60 [0.22, 1.60]

4.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.60 [0.22, 1.60]

5 Any potentially preventable perinatal death* Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.37, 1.86]

5.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.83 [0.37, 1.86]

6 Fetal acidosis Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.25 [0.03, 2.20]

6.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.25 [0.03, 2.20]

7 Apgar < 7 at 5 minutes Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.44, 1.72]

7.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.44, 1.72]

8 Infant requiring intubation/ventilation Show forest plot

1

333

Risk Ratio (M‐H, Random, 95% CI)

0.87 [0.67, 1.13]

8.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Random, 95% CI)

0.87 [0.67, 1.13]

9 Intraventricular haemorrhage Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

8.95 [0.49, 164.87]

9.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

8.95 [0.49, 164.87]

10 Bronchopulmonary dysplasia Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.55, 1.38]

10.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.87 [0.55, 1.38]

11 Necrotising enterocolitis Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.03, 3.15]

11.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.33 [0.03, 3.15]

12 Infant birthweight (grams) Show forest plot

1

333

Mean Difference (IV, Fixed, 95% CI)

38.0 [‐31.53, 107.53]

12.1 Singleton pregnancy

1

333

Mean Difference (IV, Fixed, 95% CI)

38.0 [‐31.53, 107.53]

13 Long‐term infant neurodevelopmental outcome (impairment at 2 years) Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.60 [0.30, 1.18]

13.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.60 [0.30, 1.18]

14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years) Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.20 [0.02, 1.68]

14.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.20 [0.02, 1.68]

15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified) Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.92, 1.23]

15.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.92, 1.23]

16 Sepsis (proven) (not prespecified) Show forest plot

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.60, 1.45]

16.1 Singleton pregnancy

1

333

Risk Ratio (M‐H, Fixed, 95% CI)

0.93 [0.60, 1.45]

Figures and Tables -
Comparison 5. Early ductus venosus Doppler ultrasound versus CTG
Comparison 6. Late ductus venosus Doppler ultrasound versus CTG

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [0.64, 2.55]

1.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [0.64, 2.55]

2 Survival following severe neonatal morbidity Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.66, 1.45]

3 Stillbirth Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

2.93 [0.60, 14.31]

3.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

2.93 [0.60, 14.31]

4 Neonatal death Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.47, 2.46]

4.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.07 [0.47, 2.46]

5 Any potentially preventable perinatal death* Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.22 [0.59, 2.53]

5.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.22 [0.59, 2.53]

6 Fetal acidosis Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.11 [0.01, 2.00]

6.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.11 [0.01, 2.00]

7 Apgar < 7 at 5 minutes Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [0.69, 2.37]

7.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [0.69, 2.37]

8 Infant requiring intubation/ventilation Show forest plot

1

336

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.73, 1.20]

8.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Random, 95% CI)

0.94 [0.73, 1.20]

9 Intraventricular haemorrhage Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

16.60 [0.97, 285.35]

9.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

16.60 [0.97, 285.35]

10 Bronchopulmonary dysplasia Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.61, 1.48]

10.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.95 [0.61, 1.48]

11 Necrotising enterocolitis Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.20, 4.77]

11.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.98 [0.20, 4.77]

12 Infant birthweight (grams) Show forest plot

1

336

Mean Difference (IV, Fixed, 95% CI)

25.0 [‐40.06, 90.06]

12.1 Singleton pregnancy

1

336

Mean Difference (IV, Fixed, 95% CI)

25.0 [‐40.06, 90.06]

13 Long‐term infant neurodevelopmental outcome (impairment at 2 years) Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.15, 0.79]

13.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.15, 0.79]

14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years) Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.09 [0.00, 1.59]

14.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.09 [0.00, 1.59]

15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified) Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.17 [1.02, 1.34]

15.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

1.17 [1.02, 1.34]

16 Sepsis (proven) (not prespecified) Show forest plot

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.42, 1.11]

16.1 Singleton pregnancy

1

336

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.42, 1.11]

Figures and Tables -
Comparison 6. Late ductus venosus Doppler ultrasound versus CTG
Comparison 7. Early ductus venosus Doppler ultrasound versus late

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Any perinatal death after randomisation Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.66 [0.32, 1.36]

1.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.66 [0.32, 1.36]

2 Survival following severe neonatal morbidity Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.13 [0.77, 1.65]

3 Stillbirth Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.20, 2.36]

3.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.20, 2.36]

4 Neonatal death Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.56 [0.21, 1.47]

4.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.56 [0.21, 1.47]

5 Any potentially preventable perinatal death* Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.31, 1.47]

5.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.31, 1.47]

6 Fetal acidosis Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

3.05 [0.13, 74.43]

6.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

3.05 [0.13, 74.43]

7 Apgar < 7 at 5 minutes Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.36, 1.29]

7.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.68 [0.36, 1.29]

8 Infant requiring intubation/ventilation Show forest plot

1

337

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.71, 1.21]

8.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Random, 95% CI)

0.93 [0.71, 1.21]

9 Intraventricular haemorrhage Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.51 [0.16, 1.66]

9.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.51 [0.16, 1.66]

10 Bronchopulmonary dysplasia Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.58, 1.46]

10.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.92 [0.58, 1.46]

11 Necrotising enterocolitis Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.04, 3.23]

11.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.34 [0.04, 3.23]

12 Infant birthweight (grams) Show forest plot

1

337

Mean Difference (IV, Fixed, 95% CI)

13.0 [‐59.31, 85.31]

12.1 Singleton pregnancy

1

337

Mean Difference (IV, Fixed, 95% CI)

13.0 [‐59.31, 85.31]

13 Long‐term infant neurodevelopmental outcome (impairment at 2 years) Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.75 [0.70, 4.32]

13.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.75 [0.70, 4.32]

14 Long‐term infant neurodevelopmental outcome (cerebral palsy at 2 years) Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

3.05 [0.13, 74.43]

14.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

3.05 [0.13, 74.43]

15 Infant survival at 2 years without neurodevelopmental impairment (not prespecified) Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.80, 1.03]

15.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

0.91 [0.80, 1.03]

16 Sepsis (proven) (not prespecified) Show forest plot

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.37 [0.84, 2.25]

16.1 Singleton pregnancy

1

337

Risk Ratio (M‐H, Fixed, 95% CI)

1.37 [0.84, 2.25]

Figures and Tables -
Comparison 7. Early ductus venosus Doppler ultrasound versus late